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 i 
ABSTRACT  
   
MicroRNAs are small, non-coding transcripts that post-transcriptionally regulate 
expression of multiple genes. Recently microRNAs have been linked to the etiology of 
neuropsychiatric disorders, including drug addiction. Following genome-wide sequence 
analyses, microRNA-495 (miR-495) was found to target several genes within the 
Knowledgebase of Addiction-Related Genes (KARG) database and to be highly 
expressed in the nucleus accumbens (NAc), a pivotal brain region involved in reward and 
motivation. The central hypothesis of this dissertation is that NAc miR-495 regulates 
drug abuse-related behavior by targeting several addiction-related genes (ARGs). I tested 
this hypothesis in two ways: 1) by examining the effects of viral-mediated miR-495 
overexpression or inhibition in the NAc of rats on cocaine abuse-related behaviors and 
gene expression, and 2) by examining changes in NAc miR-495 and ARG expression as a 
result of brief (i.e., 1 day) or prolonged (i.e., 22 days) cocaine self-administration. I found 
that behavioral measures known to be sensitive to motivation for cocaine were attenuated 
by NAc miR-495 overexpression, including resistance to extinction of cocaine 
conditioned place preference (CPP), cocaine self-administration on a high effort 
progressive ratio schedule of reinforcement, and cocaine-seeking behavior during both 
extinction and cocaine-primed reinstatement. These effects appeared specific to cocaine, 
as there was no effect of NAc miR-495 overexpression on a progressive ratio schedule of 
food reinforcement. In contrast, behavioral measures known to be sensitive to cocaine 
reward were not altered, including expression of cocaine CPP and cocaine self-
administration under a low effort FR5 schedule of reinforcement. Importantly, the effects 
were accompanied by decreases in NAc ARG expression, consistent with my hypothesis. 
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In further support, I found that NAc miR-495 levels were reduced and ARG levels were 
increased in rats following prolonged, but not brief, cocaine self-administration 
experience. Surprisingly, inhibition of NAc miR-495 expression also decreased both 
cocaine-seeking behavior during extinction and NAc ARG expression, which may reflect 
compensatory changes or unexplained complexities in miR-495 regulatory effects. 
Collectively, the findings suggest that NAc miR-495 regulates ARG expression involved 
in motivation for cocaine. Therefore, using microRNAs as tools to target several ARGs 
simultaneously may be useful for future development of addiction therapeutics.  
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CHAPTER 1 
GENERAL OVERVIEW 
Drug addiction is a chronic, debilitating condition that leads to psychological, 
physical, and social distress. In the clinical field, addiction is referred to as substance use 
disorder (SUD) that falls along a continuum, from mild to severe, and is characterized by 
excessive drug use, persistent desire or craving for drug, excessive time spent attempting 
to acquire drug, or continued use despite negative consequences. SUD is a pervasive 
problem in the US, where the costs to society are staggering (e.g., $193 billion in 2007; 
www.justice.gov/ndic, 2011). Therefore, much research is devoted to examining the 
neural mechanisms underlying drug reinforcement and motivation in order to find novel 
therapeutics for SUDs.  
Drugs of abuse exert their reinforcing effect primarily by activating 
mesocorticolimbic dopamine neurons that originate in the ventral tegmental area (VTA) 
and project to the nucleus accumbens (NAc), prefrontal cortex (PFC), amygdala, and 
hippocampus (Feltenstein & See, 2008; Pierce & Kumaresan, 2006). Psychostimulants, 
and in particular cocaine, act as potent reinforcers due to their ability to increase synaptic 
monoamines levels through blockade of presynaptic reuptake transporters. Although this 
action appears to be involved in the initial reinforcing phase of drug use, the persistent 
compulsion to procure drugs that characterizes dependence suggests that more enduring 
changes occur within this reward circuitry (Kalivas & Volkow, 2005). Indeed, drugs of 
abuse alter gene expression, resulting in changes in synaptic plasticity and efficacy 
(Hyman, Malenka, & Nestler, 2006; Kauer & Malenka, 2007). Such changes are thought 
to underlie the transition from recreational to compulsive drug use (Hyman & Malenka, 
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2001; Kalivas, 2009). While work in this area has focused on changes at the 
transcriptional level (e.g. DNA methylation, chromatin remodeling, transcription factors, 
etc.) (LaPlant & Nestler, 2011; Renthal & Nestler, 2009), little is known about post-
transcriptional mechanisms that also contribute to altered addiction-related gene (ARG) 
expression.  
MicroRNAs 
Before the 1990s, non-protein-coding RNA was often referred to as “junk DNA”; 
believed to have little relevance to biological function. A growing body of research over 
the past 25 years has shown that non-coding RNAs have pivotal roles in almost every 
cellular process investigated (Kloosterman & Plasterk, 2006). One class of non-coding 
RNA that has received much attention is microRNAs (miRNAs), which are highly 
conserved RNAs that regulate gene expression post-transcriptionally. miRNA genes 
reside in the genome in several forms, either as a single miRNA gene with its own 
promoter, in a cluster of several miRNAs that are transcribed together, or intronic genes 
that are transcribed with a host protein-coding gene (Berezikov, 2011). Once transcribed, 
the resulting pri-miRNA transcript folds and binds to itself imperfectly, producing a 
stem-loop hairpin structure (Fig. 1). The RNAse III endonuclease, Drosha, trims the 
double-stranded stem portion of the pri-miRNA, producing a smaller hairpin known as a 
pre-miRNA.  Pre-miRNAs are then transported out of the nucleus into the cytoplasm, 
where the loop portion of the pre-miRNA cleaved by the RNAse III enzyme Dicer 
(Bartel, 2004). Now as a double-stranded RNA molecule, (i.e., miRNA-miRNA* 
duplex), it is unbound and one strand joins with several proteins to form the miRNA-
induced silencing complex (miRISC), while the passenger strand (i.e., miRNA*) is 
 3 
typically degraded. The miRISC-associated miRNA (~22 nucleotides) binds to 
complementary sequences in the 3’ untranslated region (UTR) of a target mRNA where 
miRISC can cause translational repression, deadenylation, or endonucleolytic cleavage of 
the target mRNA, thus preventing its expression (Filipowicz, Bhattacharyya, & 
Sonenberg, 2008). Importantly, the mature miRNA needs only ~6-8 complementary 
nucleotides for which to base pair with the 3’ UTR of the target mRNA (i.e., seed 
region), so one miRNA can target several hundreds of different mRNAs in a given cell 
(Bartel, 2004). Changes in miRNA expression can therefore lead to widespread changes 
in gene expression and alteration in several cellular signaling cascades.  
MicroRNAs and Drug Abuse 
Given that drugs of abuse produce widespread changes in protein-coding gene 
expression (Maze et al., 2010; Renthal et al., 2007), finding candidate miRNAs that target 
a large proportion of addiction-related genes (ARGs) may provide a novel tool for 
normalizing drug-induced aberrant gene expression. One approach to finding candidate 
addiction-related miRNAs is to examine miRNA expression changes within brain regions 
implicated in addiction following varying levels of drug exposure. Recent studies indicate 
that several drugs of abuse regulate miRNA expression in the NAc and other regions of 
the brain reward pathway (Chandrasekar & Dreyer, 2009; Eipper-Mains et al., 2011; 
Guo, Chen, Carreon, & Qiang, 2012; Nudelman et al., 2010; Schaefer et al., 2010; 
Tapocik et al., 2014). More specifically, Hollander and colleagues (2010) found that rats 
given extended (6h/day), but not restricted (2h/day), access to cocaine self-administration 
exhibited upregulation of miR-212 in the dorsal striatum, a region involved in 
establishing habitual behavior (Everitt & Robbins, 2005). miR-212 directly targets 
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methyl-CpG binding protein 2 (MeCP2) and decreases in striatal MeCP2 are associated 
with decreases in compulsive drug-taking behavior (Im, Hollander, Bali, & Kenny, 
2010). Therefore, upregulation of miR-212 may be involved in countering cocaine’s 
effects through suppression of MeCP2. Additionally, alcohol-dependent rats exhibit 
increases in miR-206 expression in the medial PFC (mPFC; Tapocik et al., 2014), a brain 
region involved in executive control of drug-seeking behavior (Kalivas & Volkow, 
2005). miR-206 directly targets and suppresses brain-derived neurotrophic factor (BDNF) 
expression in the PFC (Tapocik et al., 2014), where decreases in BDNF in this region are 
associated with increases in motivation for cocaine (Sadri-Vakili et al., 2010). This 
suggests that increases in miR-206 likely promote the development of alcohol 
dependency through suppression of BDNF. Collectively, these findings provide evidence 
that miRNAs are altered by drug exposure and can be involved in either the pro- or anti-
addiction-related processes, depending on the brain region and target genes.  
Identification of miR-495 as a Putative Addiction-Related miRNA 
In order to find other candidate addiction-related miRNAs, we used an in silico 
approach to find miRNAs that target several addiction-related genes (ARGs) and that are 
highly expressed in brain reward-related regions. Initial bioinformatics analyses 
investigated the prevalence of miRNA binding sites within the 3’UTR of ARGs taken 
from the Knowledgebase of Addiction-Related Gene (KARG; http://karg.cbi.pku.edu.cn) 
database. Genes within KARG that have conserved miRNA-binding sites were selected 
using TargetScan (http://www.targetscan.org). Among the miRNAs that target ARGs, we 
found that miR-495 is expressed in the adult rat striatum (http://miRBase.org, Kozomara 
& Griffiths-Jones, 2014; Landgraf et al., 2007) and its predicted targets include Bdnf, 
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Camk2a, and Arc mRNAs, all of which have been implicated in drug addiction (Li, Mao, 
& Wei, 2008; McGinty, Whitfield, & Berglind, 2010; Pandey et al., 2008). The 
percentage of KARG genes containing conserved miR-495 binding sites in their 3’UTRs 
is higher than in the entire genome (Oliver, Gardiner, Bastle, Neisewander, & Perrone-
Bizzozero, 2014).  Approximately 7% of the mouse KARG genes (70 genes) are 
predicted to have highly conserved binding sites for miR-495 and similar results were 
obtained using the human or rat KARG gene sets (7.7% and 5.6 %, respectively). In 
comparison, another miRNA associated with cocaine addiction, let-7 (Chandrasekar & 
Dreyer, 2009, 2011), was predicted to target only ~3% of the mouse KARG genes and 
~2.5% of the entire genome. Thus, miR-495 is a conserved, predicted regulator of ARGs 
in mammals.  
Subsequent studies used a combination of fluorescent in situ hybridization (FISH) 
and qRT-PCR to validate the striatal expression of miR-495 and its distribution in other 
brain regions. miR-495 expressing cells were localized to the NAc, dorsal striatum, 
pyriform and neocortex (Oliver et al., 2014), with the latter consistent with miR-495 
expression in the human PFC (Mellios, Huang, Grigorenko, Rogaev, & Akbarian, 2008). 
Using qRT-PCR, we found that miR-495 was expressed in several brain regions and that 
the highest expression levels were in the NAc (Oliver et al., 2014). Interestingly, acute 
cocaine administration in mice reduced miR-495 1 h post-injection selectively in the 
NAc, but not in the mPFC, orbitofrontal cortex, or dorsal striatum (Oliver et al., 2014). 
This downregulation was rapid and transient, where cocaine downregulated NAc miR-
495 expression 1-4 h post-injection, but miR-495 levels returned to baseline levels the 
following day. Furthermore, this downregulation corresponded with increases in target 
 6 
ARG expression, suggesting a potential regulatory role. Indeed, dual luciferase assays 
validated that miR-495 directly binds to the 3’UTR of Bdnf, Arc, and Camk2a mRNA 
(Oliver et al., 2014).  
Bdnf is present in vivo as two different transcripts produced from the same 
promoter. Due to differential polyA site usage, this mRNA exists with a short (Bdnf-S) or 
a long 3’UTR (Bdnf-L) variant. Interestingly, the long 3’ UTR variant is predominantly 
localized in dendrites, rapidly translated following neuronal activation, and subsequently 
regulates LTP (An et al., 2008; Lau et al., 2010). Furthermore, the long form contains a 
greater number of miR-495 binding sites than the short form 
(http://www.targetscan.org/mmu_50/), suggesting that miR-495 would preferentially alter 
the stability and/or translation of Bdnf-L versus Bdnf-S. miR-495 also targets specific 
subunits of CaMKII (Camk2a), where the alpha subunit has a greater role in promoting 
drug abuse-related behavior than other subunits (Kourrich, Klug, Mayford, & Thomas, 
2012; Loweth et al., 2010; Wang et al., 2010). Thus, miR-495 is a lead addiction-related 
miRNA candidate due to its 1) ability to target several ARGs, 2) its high expression in 
the NAc, and 3) its regulation in the NAc by cocaine exposure.  
Aims of Research 
This dissertation research examined the hypothesis that NAc miR-495 regulates 
cocaine abuse-related behavior through targeting several ARGs. I initially tested this 
hypothesis by examining the effects of viral-mediated NAc miR-495 overexpression 
(OE) on cocaine’s acute rewarding properties in rats, specifically during expression and 
extinction of cocaine conditioned place preference (CPP). Next, I examined changes in 
NAc miR-495 and ARG expression as a result of brief (i.e. 1 day) or prolonged (i.e., 22 
 7 
days) cocaine self-administration. I then examined the effect NAc miR-495 OE and 
inhibition on cocaine SA for the following measures: 1) low and high effort schedules of 
reinforcement, 2) extinction and reinstatement of cocaine-seeking behavior, and 3) ARG 
expression. Subsequent studies examined the effect of NAc miR-495 OE on food 
reinforcement in order to test the specificity of cocaine effects. 
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CHAPTER 2 
EFFECTS OF NUCLEUS ACCUMBENS MIR-495 OVEREXPRESSION ON 
COCAINE-INDUCED GENE EXPRESSION AND COCAINE CONDITIONED 
PLACE PREFERENCE 
Epigenetic mechanisms serve as mediators of environmental effects on gene 
expression, whereby external stimuli can turn gene expression on and off. Acute 
administration of drug of abuse results in widespread changes in gene expression in the 
brain, particularly in the nucleus accumbens (NAc) of rodents (Maze et al., 2010; 
Robison & Nestler, 2011).  While much research has focused on epigenetic regulation at 
the transcriptional level in response to drugs of abuse (e.g., DNA and histone 
modifications) (McQuown & Wood, 2010; Renthal & Nestler, 2008, 2009), relatively 
fewer studies have examined post-transcriptional mechanisms of gene regulation. 
MicroRNAs (miRNAs) are small, non-coding transcripts that post-transcriptionally 
suppress gene expression through base pairing with target mRNAs (Bartel, 2004). Given 
that one miRNA can target several different mRNAs within a given cell, miRNAs are 
poised to fine-tune gene expression in multiple cellular pathways that are activated 
following environmental perturbations.  
Given the widespread expression of miRNAs in the brain, miRNAs have been 
shown to play a key role in neural development and function (Kosik, 2006; Wang, Kwon, 
& Tsai, 2012). Interestingly, the time scale for transcriptional activation of some 
miRNAs mimic those of immediate early genes (Nudelman et al., 2010; Oliver et al., 
2014), suggesting they also play a role in fast regulatory processes, including synaptic 
plasticity (Aksoy-Aksel, Zampa, & Schratt, 2014). Indeed, several miRNAs have been 
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implicated in processes relating to learning and memory (Wang et al., 2012). While 
miRNAs have been linked to several disease states and disorders (Im & Kenny, 2012), 
only recently have researchers begun to examine the relationship between miRNAs and 
drug addiction (Li, Zhao, Wang, & Yang, 2011).  
Previous work has linked changes in miRNA expression with cocaine exposure 
and reward (Chandrasekar & Dreyer, 2009, 2011; Eipper-Mains et al., 2011; Nudelman et 
al., 2010). For instance, Chandrasekar & Dreyer (2011) found that viral-mediated 
manipulation of NAc miR-124, miR-181a, and let-7 expression altered expression and 
extinction of cocaine CPP. In order to establish CPP, an animal experiences a drug state 
while confined to one compartment of an apparatus and a neutral state while confined to 
an alternate compartment during conditioning, resulting in a shift in the animal’s 
preference for the drug-paired compartment when given free-access to both 
compartments. Classical conditioning processes govern these effects, where the animal 
learns to associate the internal rewarding drug experience (i.e., unconditioned stimulus) 
with the external environmental stimuli (i.e., conditioned stimulus). The results from 
Chandrasekar & Dreyer (2011) suggest that these miRNAs regulate genes involved in 
drug reward learning and motivation.  
We previously identified miR-495 as a potential regulator of addiction-related 
genes based on three findings: 1) it is enriched in the NAc, 2) it directly targets the 
3’UTR of Bdnf and Arc, and 3) it is downregulated by acute cocaine (Oliver et al., 2014; 
Perrone-Bizzozero et al., 2009). Bdnf is critical for development and maintenance of 
synaptic structure and function (McAllister, Katz, & Lo, 1999; Poo, 2001), while Arc 
interacts with cytoskeleton proteins involved in spine formation and regulates AMPA 
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receptor endocytosis (Bramham, Worley, Moore, & Guzowski, 2008; Shepherd et al., 
2006). Both genes are upregulated in the NAc following acute drug administration 
(Graham et al., 2007; Loweth et al., 2010; Samaha, Mallet, Ferguson, Gonon, & 
Robinson, 2004); therefore, these genes may be involved in the initial plasticity that 
occurs following drug administration. Indeed, downregulation of Bdnf and Arc expression 
in the NAc impairs expression of drug CPP (Graham et al., 2009; Lv, Xu, Han, & Cui, 
2011).  
Along with cocaine-induced decreases in NAc miR-495, we previously found that 
acute cocaine administration in mice increases NAc Bdnf expression at a similar time 
point (i.e., 2 h post injection) (Oliver et al., 2014). Therefore, we initially sought to 
counter downregulation of NAc miR-495 and upregulation of Bdnf expression by using a 
viral-mediated overexpression (OE) approach in rats. We chose to target the shell 
subregion of the NAc (NAcSh) for miR-495 OE based on data that acute cocaine 
increases Bdnf expression in the NAcSh, but not the core, of rats (Graham et al., 2007). 
Furthermore, we tested the effect of NAcSh miR-495 OE on the initial rewarding effects 
using cocaine CPP (Experiment 2b). Given the established roles of target ARGs in the 
NAc on drug CPP, we predicted that NAcSh miR-495 OE would decrease cocaine CPP, 
as well as target gene expression.  
Methods 
Animals 
Male Sprague–Dawley rats (Charles River, San Diego, CA) (N=33; 200-225g) 
were individually housed in a climate-controlled facility with a 14-h dark/light cycle 
(lights off at 7 AM) with ad libitum access to food and water. Housing and care were 
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conducted in accordance with the 8th edition of the Guide for the Care and Use of 
Laboratory Animals (Committee, 2011). Prior to surgery, animals were acclimated to 
handling (~2 min/day) for 7 days.  
Intracranial viral injections 
Animals in both experiments were placed under isoflurane anesthesia (2-3%) and 
positioned in a stereotactic frame (Kopf, Tujunga, CA, USA). An incision was made on 
the head (~2 cm) and skin was separated to expose the top of the skull. Holes were drilled 
in reference to bregma and virus was infused bilaterally through guide cannula aimed at 
the nucleus accumbens shell (NAcsh; +1.6 mm AP, ±1.1 mm ML, -6.8 mm DV from 
Bregma; Paxinos & Watson, 2007). Lentiviral vectors contained either green fluorescent 
protein (GFP; LV-GFP; 8.28 x 108 IUF/mL), which also expresses a non-targeting 
sequence, or GFP + pri-miR-945 (LV-miR-495; 1.32 x 109 IUF/mL; System Biosciences 
Inc. Mountain View, CA, USA). The infusions (2 µl/side) were given at a rate of 0.2 
µL/min through a 30-gauge injector (Plastics One, Roanoke, VA, USA) connected via 
Tygon microbore tubing (Norton Performance Plastics, Akron, OH, USA) to a 25-µL 
syringe (Hamilton Co., Reno, NV, USA) housed in an infusion pump (CMA 
Microdialyis, North Chelmsford, MA, USA). Injectors extended 1 mm below guide 
cannula and were left in place for 10 min post-infusion to allow for virus diffusion.  
Acute cocaine administration 
For the acute cocaine experiment, rats (n = 22) were infused with their respective 
virus, counterbalanced by weight. Two weeks later, rats were treated with an acute 
injection of either saline (1 mL/kg) or cocaine (15 mg/kg, i.p.) and sacrificed 2 h later. 
The cocaine dose and sacrifice time were chosen based on previous data showing 
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cocaine-induced decreases in miR-495 and increases in Bdnf mRNA and protein 
expression in mice at this time point (Oliver et al., 2014). Brains were rapidly collected, 
frozen in 2-methylbutane (-50˚C), and stored at -80˚C until further processing.  
CPP Apparatus 
Conditioning took place in rectangular Plexiglas chambers as previously 
described (Peartree et al., 2012). Each chamber contained a removable solid partition that 
separated the chamber into two equal-sized compartments, each measuring 
35 × 24 × 31 cm high. One compartment had corncob bedding beneath a wire 1 × 1 cm 
grid floor and alternating black and white vertical stripes on the walls. The other 
compartment had pine-scented bedding beneath a parallel bar floor (5 mm diameter) and 
alternating black and white horizontal stripes on the walls. On the pre- and post-
conditioning test days, the removable center partition of the apparatus was replaced by a 
similar partition that contained an opening in the center (28 × 6 cm), allowing the rats 
free-access to the adjacent compartments simultaneously. A rectangular tower measuring 
70 × 24 × 74 cm high of clear Plexiglas was used as an extension of the apparatus to 
prevent the rats from escaping from the chamber while maintaining the ability to record 
their behavior via an overhanging video camera. The conditioning room was dimly lit 
with two overhead lamps, each containing a 25-Watt light bulb providing equal light 
distribution for each conditioning chamber. Unpublished data from our laboratory 
established that adult experimentally naïve rats showed no preference for a particular 
compartment (i.e., unbiased apparatus). A camera (Panasonic WV-CP284, color CCTV, 
Suzhou, China) used to record testing sessions was mounted 101 cm above the center of 
the apparatus. A WinTV 350 personal video recorder (Hauppage, NJ, USA) captured live 
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video and encoded it to MPEG streams. A modified version of TopScan Software (Clever 
Sys., Inc. Reston, VA, USA) used the orientation of an animal's body parts to track its 
location, which yielded measures of time spent in each compartment. 
Baseline Preference 
One week following viral infusions, rats (n = 17) in the CPP experiment were 
placed individually into their assigned CPP apparatus where they had free access to both 
compartments for a 15-min habituation period. This procedure was repeated across the 
next 2 consecutive days with the starting compartment counterbalanced across days and 
the time spent in each compartment recorded to assess initial baseline preference. The 
tracking software determined the location of the rat’s head. Time spent in each 
compartment was averaged across the two baseline tests to determine each rat's initial 
side preference. Rats that failed to demonstrate at least five compartment crossovers 
during either baseline day were excluded from the experiments due to inadequate 
environmental exploration. 
Conditioning, Testing, and Extinction 
Conditioning sessions took place over 4 consecutive days, where rats were 
confined either to the initially non-preferred side of the apparatus for 30 min following a 
cocaine injection (15 mg/kg, i.p.) or were confined in the initially preferred side of the 
apparatus following a saline injection (1 mL/kg). These session types alternated across 
consecutive days (e.g., cocaine-saline-cocaine-saline). Whether the first conditioning 
session was on the initially preferred or non-preferred side was counterbalanced across 
groups. On the day following the last conditioning session, all rats were given a 15-min 
place preference test. On the three days following the test day, rats were placed in the box 
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with access to both sides of the apparatus, but received no injections prior to placement 
(i.e., extinction). The day following the last extinction session, rats were sacrificed and 
brains were rapidly collected, frozen in 2-methylbutane (-50˚C), and stored at -80˚C until 
further processing. 
qRT-PCR 
 NAc tissue was dissected using a 2 mm brain punch (Harris Unicore™). RNA 
was isolated via standard Trizol® (Invitrogen) extraction followed by ethanol 
precipitation in the presence of glycogen to recover both mRNA and small RNAs. 
Starting with 15 ng of purified RNA, cDNA was prepared using the Taqman® 
MicroRNA Reverse transcription kit (Applied Biosciences, Grand Island, NY, USA) and 
Taqman® MicroRNA Assay primers (Life Technologies, Grand Island, NY, USA) for 
miR-495 and U6. For mRNA qPCR, cDNA was prepared using the SuperScript II First-
Strand Synthesis system (Life Technologies) and quantified using Power SYBR Green 
PCR Master Mix (Life Technologies) with primers designed against selected targets 
(Bdnf-L: Forward GCCACTGAAATGCGACTGAA, Reverse 
CATTCCCCACCTCCATCTAGAC; Bdnf-Pan: Forward 
GACTCTGGAGAGCGTGAAT, Reverse CCACTCGCTAATACTGTCAC; Arc: 
Forward GGTAAGTGCCGAGCTGAGATG, Reverse CGACCTGTGCAACCCTTTC) 
and compared to a control transcript (Gapdh: Forward CCACAGTCCATGCCATCACT, 
Reverse GCCTGCTTCACCACCTTCTTG). Bdnf-Pan refers to the total sum of Bdnf 
mRNA that includes both Bdnf-L and Bdnf-S mRNA. Relative expression was 
determined using the comparative 2-ΔCt method (Livak & Schmittgen, 2001). 
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Data Analysis 
 The acute cocaine experiment was analyzed using a two-way ANOVA with Drug 
(saline vs. cocaine) and Virus (LV-GFP vs. LV-miR-495) as between-subjects factors. 
The CPP experiment was analyzed using a mixed-factor two-way ANOVA with Day 
(baseline, test, extinction) as a within-subjects factor and Virus as a between-subjects 
factor. Significant interactions for both experiments were followed by tests for simple 
effects. Comparisons of interest (test day vs. extinction day 3) were analyzed using 
paired-sample t-tests with Bonferroni correction for multiple comparisons (alpha 
level/number of comparisons). qRT-PCR data were analyzed using student t-tests. 
Results were considered statistically significant if p < 0.05.  
Results 
Acute Cocaine Experiment 
 We found that NAcSh miR-495 OE blocked the cocaine-induced decrease in NAc 
miR-495 expression (Virus x Drug treatment: F(1, 18) = 5.19, p < 0.05; Virus: F(1, 18) = 
8.59, p < 0.01; Drug treatment: F(1, 18) = 4.80, p < 0.05). While cocaine significantly 
reduced NAc miR-495 expression in LV-GFP controls, rats that received LV-miR-495 
and cocaine had significantly greater NAc miR-495 levels than the LV-GFP-cocaine 
group and did not differ from the LV-miR-495 group that received saline (Fig. 2; tests for 
simple effects, ps < 0.05). LV-miR-495 also blocked the cocaine-induced increase in 
Bdnf-Pan mRNA expression (Virus x Drug treatment: F(1, 13) = 7.20, p < 0.05; Virus: F(1, 
13) = 19.21, p < 0.001; Drug treatment: F(1, 13) = 14.20, p < 0.01), where cocaine increased 
Bdnf-pan mRNA expression in LV-GFP controls and the LV-miR-495-cocaine group had 
significantly lower NAc Bdnf-Pan mRNA levels than the LV-GFP-cocaine group and did 
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not differ from the LV-miR-495-saline group (Fig. 3A; tests for simple effects, ps < 
0.05). Although we did not detect a cocaine-induced decrease in Bdnf-L mRNA 
expression in the LV-GFP groups, LV-miR-495 produced an overall decrease in NAc 
Bdnf-L mRNA expression (Fig. 3B; Virus x Drug treatment: F(1, 16) = 2.46, not 
significant; Virus: F(1, 16) = 25.16, p < 0.001; Drug treatment: F(1, 16) = 1.24, n.s.). 
CPP Experiment 
 We found that both virus groups exhibited significant cocaine CPP expression, 
but did not differ from each other during either baseline or test day (Fig. 4; Day: F(1, 15) = 
25.98, p < 0.0001; Virus: F(1, 15) = 0.11, n.s.; Day x Virus: F(1, 16) = 0.11, n.s.). While both 
groups had a significant trend toward extinguishing cocaine CPP by the third day (Fig. 5; 
Day: F(3, 45) = 2.56, p = 0.067; Virus: F(1, 14) = 0.87, n.s.; Day x Virus: F(3, 45) = 0.36, n.s.), 
only the LV-miR-495 group had a significant decrease in CPP on extinction day 3 
compared to test day (LV-GFP: t7 = 0.69, post-hoc Bonferroni, n.s.; LV-miR-495: t7 = 
2.98, Bonferroni, p < 0.025,). Furthermore, the LV-miR-495 group exhibited a significant 
linear trend in CPP across extinction (F(1, 8) = 6.73, p < 0.05), whereas the LV-GFP group 
had no significant trend (F(1, 7) = 0.45, n.s.), indicating the LV-miR-495 group was 
decreasing across days, while the LV-GFP group remain the same. Following testing, the 
LV-miR-495 group exhibited greater NAc miR-495 levels (Fig. 6A; t11 = 2.34, p < 0.05) 
and reduced Bdnf-L (Fig. 6B; t12 = 3.18, p < 0.01), Bdnf-Pan (Fig. 6C; t12 = 2.92, p < 
0.05), and Arc (Fig. 6D; t12 = 4.96, p < 0.01) mRNA compared to the LV-GFP group.  
Discussion 
In this chapter, we found that NAcSh miR-495 OE facilitated extinction of CPP, 
but did not affect CPP expression. These effects were accompanied by miR-495 OE-
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induced decreases in NAc Bdnf and Arc mRNA. Furthermore, we found that NAcSh 
miR-495 OE was able to prevent cocaine-induced downregulation and upregulation of 
miR-495 and Bdnf mRNA, respectively. Our findings suggest that miR-495 OE is able to 
prevent some cocaine-induced changes in gene expression and has effects on specific 
aspects of cocaine reward-related behavior.  
We considered several explanations for the selective effect of miR-495 expression 
on extinction, but not initial expression, of cocaine CPP. First, the lack of an effect on 
expression of CPP is not likely due to a floor effect because we used a fairly high cocaine 
dose during conditioning (15 mg/kg, i.p.) in order to produce a robust CPP. Furthermore, 
we observed a decrease in the initial magnitude of CPP across extinction in the miR-495 
OE group. It was also unlikely that the virus did not produce adequate OE because we 
validated that miR-495 OE occurred in these animals following behavioral testing and we 
have previously shown that this viral vector can increase miR-495 expression at the time 
point when conditioning and testing had occurred (i.e., 1 week post-infusion) (Bastle et 
al., 2014). One possibility of a selective effect on extinction is the length of time elapsed 
since the last cocaine injection, given that we have found that motivation for drug 
increases with longer periods of abstinence (Tran-Nguyen et al., 1998). Thus, if NAcSh 
miR-495 OE produces its effects by reducing motivation for cocaine, then one might 
expect to see no effect initially (i.e., initial CPP test day) but to observe attenuated CPP at 
later time points (i.e., extinction test days). Although the present findings are on a smaller 
time scale, previous research has found that both NAc BDNF expression and motivation 
for cocaine increase as the withdrawal period increases (i.e., incubation effect) (Grimm et 
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al., 2003; Li et al., 2013). Thus, it is possible that miR-495 OE may attenuate expression 
of cocaine CPP if testing is delayed to a time when motivation to seek cocaine is higher. 
Another possibility is that NAcSh miR-495 OE is impacting learning, such that 
the CPP was not as well established and therefore extinguished more rapidly. For 
instance, Arc is a plasticity-related gene that is involved in several forms of learning, 
including memory consolidation (Guzowski et al., 2000; Plath et al., 2006). Arc 
knockdown produces deficits in recall of spatial and fear memories (Guzowski et al., 
2000; Ploski et al., 2008). Perhaps NAcSh miR-495 OE reduced Arc expression to a level 
that weakened the establishment of memory for the drug-associated context. Either way, 
NAcSh miR-495 OE accelerates the rate of extinction compared to controls and this may 
have overlapping and/or distinct effects on drug motivation and learning and memory.  
We chose to target the NAcSh for miR-495 OE because cocaine selectively 
upregulates Bdnf expression in this subregion, and in turn, manipulation of Bdnf signaling 
in the NAcSh alters cocaine abuse-related behavior (Graham et al., 2007). The NAcSh is 
involved in extinction of drug seeking, where inactivation by AMPA receptor antagonists 
or GABA agonists increases responding during extinction (Millan & McNally, 2011; 
Peters, LaLumiere, & Kalivas, 2008). This suggests that activity in the NAcSh is engaged 
during inhibition of responding for drug during extinction. The NAcSh receives inputs 
from several regions involved in extinction learning, such as the basolateral amygdala 
(BLA), infralimbic prefrontal cortex (IL), and dorsal hippocampus (DH). The 
glutamatergic projections from the BLA and IL to the NAcSh are recruited during 
extinction and inactivation of this pathway reduces extinction learning (Hamlin, Clemens, 
Choi, & McNally, 2009; Millan & McNally, 2011; Peters et al., 2008). The DH is 
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involved in forming associations between contextual and rewarding stimuli (Meyers, 
Zavala, Speer, & Neisewander, 2006). Therefore, DH projections to the NAcSh may be 
recruited during CPP extinction, where information about the lack of reward in a 
particular context is integrated in the DH and sent to the NAcSh to inhibit responding. 
Output regions of the NAcSh may also be involved in these effects. Indeed, the NAcSh 
GABAergic neurons project to the lateral hypothalamus (LH) and inhibit this region 
during extinction and NAcSh inactivation increases drug seeking via disinhibition of LH 
activity (Millan, Furlong, & McNally, 2010). Collectively, our findings agree with 
previous work that establishes a role of the NAcSh in extinction of drug seeking. Thus, 
miR-495 OE may alter the activity of NAcSh neurons and their associated circuitry to 
enhance extinction processes.  
In addition to Bdnf and Arc, both Camk2a and Cnr1 are other miR-495 targets 
that might be involved in our behavioral effects. Camk2a encodes for 
calcium/calmodulin-dependent protein kinase II alpha (CaMKIIα), which is another 
plasticity-related gene whose target substrates include AMPA and NMDA receptors 
(Colbran & Brown, 2004). miR-495 directly targets the 3’UTR of Camk2a (Oliver et al., 
2014) and NAcSh miR-495 OE downregulates Camk2a mRNA (Table 1) (Bastle et al., 
2014). Transgenic mice expressing autonomously-active striatal CaMKIIα exhibit 
increases in cocaine-induced locomotor activity and CPP (Kourrich et al., 2012). 
Furthermore, viral-mediated increases in NAcSh CaMKIIα also increase drug-induced 
locomotion (Loweth et al., 2010), suggesting this molecule has a facilitating effect on 
drug abuse-related behavior. Cnr1 encodes for the cannabinoid receptor type 1 (CB1R), 
which are G protein-coupled receptors functioning as presynaptic heteroreceptors on both 
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glutamatergic and GABAergic neurons; thereby activation of CB1R inhibits presynaptic 
release. We previously found through microarray analysis that Cnr1 mRNA is 
downregulated in the NAc by miR-495 OE (Table 1). Similar to downregulation, intra-
accumbal CB1 antagonist administration facilitates extinction learning in rats 
(Khaleghzadeh-Ahangar & Haghparast, 2015). While ultrastructural localization studies 
in the NAc have shown CB1R expression on the soma and dendrites of GABAergic 
interneurons, they are also present on glutamatergic cortico-striatal terminals in the NAc 
(Pickel, Chan, Kearn, & Mackie, 2006). Therefore, pharmacological blockade would not 
be specific to one cell type versus the other. Similarly, if our effects were Cnr1-mediated, 
we would need to determine whether they were occurring through local GABAergic 
interneurons or through GABAergic projection neuron where CB1R would be expressed 
on terminals in output regions of the NAc. Future research into the differential roles of 
efferent versus local NAc CB1R action on drug-related extinction processes is warranted.  
Our finding that miR-495 OE decreased Bdnf and Arc mRNA expression in 
NAcSh when measured following behavioral testing conflicts with previous work 
demonstrating that downregulation of these genes impairs drug CPP expression (Bahi, 
Boyer, Chandrasekar, & Dreyer, 2008; Lv et al., 2011). One possibility for our lack of an 
effect on CPP expression is the degree to which miR-495 OE is downregulating the 
measured ARGs. Although we observed a  >50% reduction in mRNA, perhaps knockout 
and antisense procedures produce greater reductions in functional protein output. Also, 
we cannot rule out that miR-495 OE may be reducing expression of other genes that 
produce opposite effects on drug CPP. Indeed, our microarray results showed that NAc 
miR-495 OE also decreases Per2 mRNA expression (Table 1). Per2 encodes for the 
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period circadian clock 2 (Per2) protein which has a critical role in circadian rhythms 
(Rosenwasser, 2010). Interestingly, Per2 is upregulated in the striatum 30 min following 
repeated cocaine administration (Uz et al., 2005), and knockout mice exhibit increased 
cocaine-induced hyperlocomotion (Abarca, Albrecht, & Spanagel, 2002) and alcohol 
intake (Spanagel et al., 2005). Thus, Per2 expression may counter cocaine’s action and 
downregulation may produce an addiction-like phenotype. Therefore, the balance 
between miR-495 OE-induced repression of genes that inhibit versus promote CPP 
expression may have not been tipped toward the former enough to regulate this aspect of 
CPP.  
In conclusion, we demonstrated that NAcSh miR-495 OE blocks cocaine-induced 
gene expression and facilitates extinction of cocaine CPP. These results suggest that 
although miR-495 may not alter the rewarding effects of cocaine given that CPP 
expression was not altered, increasing NAcSh miR-495 may target genes involved in 
learning to inhibit reward-seeking behavior and/or motivation evoked by the cocaine-
associated context. This may give insight into the possible use of microRNAs as tools to 
control gene expression associated with specific aspects of drug abuse-related behavior.  
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CHAPTER 3 
PROLONGED COCAINE SELF-ADMINISTRATION DOWNREGULATED 
MIR-495 IN THE NUCLEUS ACCUMBENS 
Although several models exist to examine drug abuse-related behavior following 
experimenter-delivered drug administration (e.g., locomotor sensitization, CPP, etc.), the 
self-administration (SA) model is considered the “gold standard” because it has high 
face, construct, and predictive validity for modeling human addiction (Panlilio & 
Goldberg, 2007), although predictive validity is difficult to establish due to relatively few 
effective compounds available to treat addiction. This is especially the case for 
psychostimulants where no FDA-approved treatment exists. In the SA model, an animal 
learns to perform an operant response in order to receive a drug reinforcer, thereby 
requiring volitional behavior in contrast to experimenter-delivered drug administration 
models. Furthermore, previous studies have found that molecular factors in the NAc, 
such as CREB signaling and MeCP2 (Carlezon et al., 1998; Deng et al., 2010; Larson et 
al., 2011; Lewis & Olive, 2014), have differential functions in drug abuse-related 
behavior depending on whether the drug is experimenter-delivered versus self-
administered. Thus, it is important to validate the relevance of drug-induced changes in 
gene expression profiles to addiction with SA models.   
Similar to experimenter-delivered cocaine administration, levels of Bdnf, 
Camk2a, and Arc are all upregulated in the NAc following cocaine SA (Graham et al., 
2007; Wang et al., 2010; Zavala, Osredkar, Joyce, & Neisewander, 2008). Interestingly, 
upregulation of Bdnf and Camk2a expression occurs in the NAc shell, but not the core 
(Graham et al., 2007; Wang et al., 2010). These region-specific effects on gene 
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expression may speak to the different roles that the NAc core and shell play in drug 
reinforcement. For instance, the shell is involved in processing the unconditioned 
reinforcing effects of drugs, whereas the core is involved in processing the conditioned 
reinforcing effects (Kalivas & Volkow, 2005; Yager, Garcia, Wunsch, & Ferguson, 
2015). Given that Bdnf, Camk2a, and Arc are all plasticity-related genes, their expression 
in the NAc shell may be altered during cocaine SA as the incentive value of cocaine 
presumably increases with increasing periods of exposure to drug (Robinson & Berridge, 
1993).  
While acute cocaine downregulates NAc miR-495 (Chapter 2), we found that 
varying degrees of experimenter-delivered cocaine administration results in dynamic 
changes in NAc miR-495 expression. For instance, repeated cocaine injections in mice 
across 5 days does not alter NAc miR-495 levels (Oliver et al., 2013). However, a 
priming injection after a 1-week withdrawal period from repeated daily injections (5 
days) reduced NAc miR-495 expression to a similar extent as acute administration 
(Oliver et al., 2013). Therefore, NAc miR-495 downregulation is dependent on both the 
degree and timing of cocaine exposure. 
Here, we sought to test the effects of varying degrees of cocaine SA on NAc miR-
495 expression. We chose to measure expression in the NAc core and shell following 1 or 
22 days of cocaine SA in order to compare different cocaine SA histories. We also 
measured ARG expression in order to examine if levels would correspond to any changes 
in NAc miR-495 expression. We hypothesized that cocaine SA would produce 
differential gene expression depending on SA history, and that these effects may be 
specific to the NAc core or shell.  
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Methods 
Animals 
Male Sprague–Dawley rats (Charles River, San Diego, CA) (N=33; 200-225g) 
were individually housed in a climate-controlled facility with a 14-h dark/light cycle 
(lights off at 7 AM). The rats had ad libitum access water throughout the experiments and 
initially they had ad libitum access to food as well. Housing and care were conducted in 
accordance with the 8th ed. Guide for the Care and Use of Laboratory Animals 
(Committee, 2011). Prior to surgery, animals were acclimated to handling (~2 min/day) 
for 7 days. 
Surgery 
Catheters were constructed from Silastic tubing (10 cm in length, inner diameter 
0.012, outer diameter 0.025 inches, Dow Corning, Midland, MI, USA) connected to a 22 
gauge nonferrous metal cannula encased within a plastic screw connector (Plastics One, 
Roanoke, VA, USA). The free end of the catheter was implanted into the jugular vein and 
other end was secured to the skull with dental acrylic cement under isoflurane anesthesia 
(2-3%) as described previously (Zavala, Biswas, Harlan, & Neisewander, 2007). 
Incisions were sutured and treated with a topical antibiotic and the rats were given 
buprenorphine (0.05 mg/kg, s.c.) analgesia and an anti-inflammatory agent (meloxicam; 1 
mg/kg, s.c.). Patency of the catheters was maintained throughout the experiment by daily 
flushing with 0.1 ml timentin (66.67 mg/mL; bioWORLD, Dublin, OH) in saline solution 
containing 70 units/mL heparin sodium. Catheter patency was tested periodically with 0.8 
g methohexital sodium (Brevital, Sigma, St. Louis, MO), a dose that produces rapid loss 
 25 
of muscle tone only when administered i.v. Rats were given 7 recovery days in their 
home cages and were handled and weighed daily. 
Apparatus 
Training and testing were conducted in Plexiglas operant conditioning chambers 
(20 × 28 × 20 cm) equipped with a food pellet dispenser and a food well located between 
two levers mounted on the front panel (Med Associates, St. Albans, VT). A cue light was 
mounted above one lever, a tone generator (500 Hz, 10 dB above background noise) was 
mounted on the side wall near a lever and a house light was mounted on the rear wall 
opposite the levers. The lever below the cue light and nearest to the tone generator was 
designated as the active lever. Each conditioning chamber was housed within its own 
ventilated, sound-attenuating cabinet. An infusion pump containing a 10-ml syringe was 
located outside of the cabinet. Tygon tubing connected to the syringe was attached to a 
liquid swivel (Instech, Plymouth Meeting, PA) suspended above the operant conditioning 
chamber. The outlet of the swivel was fastened to the catheter via Tygon tubing that ran 
through a metal spring leash (Plastics One). The leash fastened onto the plastic screw of 
the cannula that was anchored on the animal’s head. 
Cocaine Self-Administration 
Self-administration (SA) began 7 days post-surgery. Two days prior to the first 
session, rats were placed on mild food restriction (16 g/day) to facilitate lever pressing. 
Rats were then randomly assigned to receive either 1 (n = 11) or 22 days (n = 12) of SA 
(e.g., SA1, SA22). In order to define acquisition of SA, we established a criterion where 
rats were only included in the experiment if they received at least 12 infusions within the 
first session. Rats were given a minimum of 2 h and a maximum of 8 h to meet this 
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criterion and the session was terminated for a given rat once the criterion was met. 
During the first session, cocaine was delivered on a fixed ratio (FR) 1 schedule of cocaine 
reinforcement (0.9375 mg/kg/0.1mL infusion), with the relatively high cocaine dose 
chosen to increase rates of acquisition during the first session. Completion of the required 
schedule resulted in activation of both a cue light above the active lever and a tone 
stimulus, and 1 s later the infusion pump was activated for 6 s. The cues and infusion 
pump were then terminated concurrently with illumination of the house light for a 20-s 
timeout period during which lever presses were recorded but had no consequences. Lever 
presses on an inactive control lever were also recorded but had no consequences. 
Controls in both the SA1 and SA22 groups received saline infusions and cues yoked to a 
cocaine partner, but lever presses produced no consequences (n = 11). Following the first 
session, the SA22 group and their saline-yoked controls went on to continue SA training, 
which consisted of daily 2-h sessions (6 days/week; 0.9375 mg/kg/infusion) that began 
on an FR1 schedule and progressed to a VR5 schedule of cocaine reinforcement. Once 
rats stabilized on the VR5 for 3 consecutive days with <15% variance in the number of 
infusions received across days, they received gradual increases in daily food rations (i.e., 
18, 20, then 22g/day for the remainder of the experiment). Rats in both the SA1 and 
SA22 groups were sacrificed one hour following the last session. This time frame was 
chosen based on our previous time course of NAc miR-495 expression following acute 
cocaine administration in mice (Oliver et al., 2014). Brains were rapidly extracted, frozen 
in 2-methylbutane, and stored at -80°C until further processing. 
qRT-PCR 
 Procedures were identical to Chapter 2, with the exception that the NAc core and 
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shell were dissected separately using 1.25 mm and 2 mm brain punches (Harris 
Unicore™; Fig. 7) and the additional use of primers for Camk2a mRNA (Forward 
TATCCGCATCACTCAGTACCTG, Reverse GAACTGGACGATCTGCCATTT).  
Western Blot 
NAc tissue punches from the contralateral hemisphere from the hemisphere that 
was used for RNA (counterbalanced across groups) was placed in a neuronal protein 
extraction reagent (N-PER, G-Biosciences, USA) containing a protease inhibitor cocktail 
and 1 mM EDTA. Tissue was homogenized with a polypropylene pestle and a Branson 
sonicator (Danbury, CT), and then centrifuged at 10,000 x g at 4°C for 10 min. The 
supernatant was then stored at -80°C until further analysis. Protein concentrations were 
determined using the Bradford assay (Bio-Rad, Hercules, CA). For immunoblot analysis, 
samples (30 µg of protein per lane) were subjected to sodium dodecyl sulfate (SDS)-
polyacrylamide gel electrophoresis using 4-20% precast gels (BioRad, Hercules, CA, 
USA). Proteins were transferred to nitrocellulose membranes, pre-blocked with 
StartingBlock ™ blocking buffer (ThermoFisher Scientific) for 30 min before overnight 
incubation with the following primary polyclonal antibodies: mouse anti-CaMKIIα 
(Santa Cruz, sc-13141, Dallas, TX, USA; 1:1000 dilution), rabbit anti-Arc (Synaptic 
Systems, 156 003, Goettingen, Germany; 1:2000), and as a loading control, mouse anti-
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (Abcam, ab8245, Cambridge, 
MA, USA; 1:10,000 dilution). Membranes were then washed and incubated with 
horseradish peroxidase (HRP)-conjugated donkey anti-mouse (Abcam, ab6789; 1:10,000 
dilution) and anti-rabbit IgG antisera (Abcam, ab6721; 1:10,000 dilution) for 2 h, and 
immunoreactive bands were detected by enhanced chemilluminescence (Perkin Elmer, 
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Waltham, MA, USA) and exposure to Kodak Bio-Max films. Developed films were 
scanned and analyzed using ImageJ software. For each sample, the optical density of the 
target gene band was divided by the corresponding GAPDH band in order to yield a 
target gene/GAPDH ratio. 
Data Analysis 
 Behavioral data and saline qRT-PCR data were analyzed using independent-
samples student t-tests. qRT-PCR data were analyzed using a one-way ANOVA with 
post-hoc Tukey tests. Significant interactions for both experiments were followed by tests 
for simple effects. Comparisons of interest for ARG expression (Saline & SA1 vs. SA22, 
based on miR-495 data) were analyzed using independent-samples t-tests with Bonferroni 
correction for multiple comparisons (alpha level/number of comparisons). Otherwise, 
results were considered statistically significant if p < 0.05. 
Results 
The two cocaine SA groups did not differ in the total number of responses 
performed (Fig. 8A, B; t21 = 1.38, n.s.) or cocaine infusions received (Fig. 8C, D; t21 = 
1.13, n.s.) during their respective test sessions. For qRT-PCR, saline-yoked controls were 
included at each time point, but did not significantly differ from one another for NAc 
miR-495 or ARG expression (data not shown; range from t5-9 = 0.09-0.95, all n.s.), so 
they were combined into one group. We found that NAcSh miR-495 expression was 
significantly reduced compared to both the Saline and SA1 groups (Fig. 9; F2, 19 = 8.61, p 
< 0.01; post-hoc Tukey, ps < 0.05), but no difference was found between the Saline and 
SA1 group (Tukey, n.s.). No differences in NAc core (NAcC) miR-495 expression were 
observed across groups (Fig. 10; F2, 25 = 0.33, n.s.).  
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Upon measuring ARG expression in the NAcSh, we found no change in Bdnf-L 
(Fig. 11A; F2, 27 = 0.81, n.s.), or Bdnf-Pan (Fig. 11B; F2, 27 = 0.87, n.s.) mRNA. Although 
we found no difference between SA1 and Saline groups in Arc mRNA (F2, 25 = 2.82, p = 
0.08, post-hoc Bonferroni, n.s.), we found an increase in the SA22 group compared to the 
Saline group (Fig. 12A; Bonferroni, p ≤ 0.025). Furthermore, we found a significant 
linear trend across all groups (p < 0.05), indicating Arc mRNA levels were increasing as 
cocaine exposure increased. However, we found no difference in Arc protein across 
groups (Fig. 12B; F2, 31 = 1.01, n.s.). For Camk2a mRNA and protein, neither cocaine SA 
group differed from the Saline group, but the SA22 group showed significantly increased 
levels compared to the SA1 group (Fig. 13A, B; mRNA: F2, 25 = 2.92, p = 0.07, 
Bonferroni, p = 0.03 for SA1 vs. SA22; Protein: F2, 30 = 3.89, p < 0.05, Tukey, p < 0.05 
for SA1 vs. SA22). Both Camk2a mRNA and protein had significant quadratic trends 
across all groups (ps < 0.05), indicating a U-shaped curve of Camk2a expression as 
cocaine exposure increased.  
Discussion 
Here we found that prolonged, but not brief, cocaine SA decreases NAcSh miR-
495 expression. This effect was region-specific, as there were no group differences in the 
NAcC. The difference in miR-495 across the cocaine SA groups is not likely due to 
differences in cocaine exposure on test day, as both SA groups had similar intake on their 
respective test days. We also found that NAcSh Arc mRNA expression was increased in a 
similar pattern as the miR-495 decrease across cocaine SA groups. In contrast, there were 
no group differences in Bdnf mRNA in NAcSh and Camk2a levels in this region 
appeared to decrease slightly during initial cocaine exposure and then normalized 
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following prolonged cocaine SA. The latter is suggested based on the significant decrease 
in Camk2a mRNA in SA1 relative to SA22 and because although neither SA group 
differed from saline controls, the SA22 group better approximated saline control levels of 
Camk2a than the SA1 group. These data suggest miR-495 and ARG expression are 
regulated in a time- and region-specific manner during cocaine SA.  
Although the NAc core and shell are situated in close proximity, our selective 
effects in the NAc shell versus the core are not surprising given how these subregions 
differ in circuitry and morphology. While both the core and shell receive inputs from 
dopaminergic neurons originating in the ventral tegmental area (VTA) and glutamatergic 
neurons originating from the prefrontal cortex (PFC), amygdala, and hippocampus, the 
shell receives input specifically from the IL subregion of the medial PFC and the core 
receives input from the prelimbic (PrL) cortex (Yager et al., 2015). Also, while both 
regions send projections to the ventral pallidum and substantia nigra, these projections 
are to different subregions within these areas. Furthermore, the shell sends additional 
projections to the ventral tegmental area, lateral hypothalamus, and extended amygdala, 
while the core sends projections to the entopeduncular nucleus (Heimer, Zahm, Churchill, 
Kalivas, & Wohltmann, 1991). The predominant projection neurons from the NAc are 
GABAergic medium spiny neurons (MSNs) and the dendritic morphology of MSNs 
slightly differs across NAc subregions. For instance, the shell has a lower density of 
dendritic spines, less terminal segments, and less branch segments than the core 
(Meredith, Agolia, Arts, Groenewegen, & Zahm, 1992). As such, the shell MSNs have 
greater input resistance and attenuated negative resting membrane potential compared to 
those of the core (Pennartz, Dolleman-Van der Weel, & Lopes da Silva, 1992).  
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NAc MSNs can often be divided into two populations that predominantly express 
either dopamine D1 receptors (D1R) or D2Rs. These receptors have functionally distinct 
actions following stimulation, where D1R stimulation increases adenylyl cyclase and 
cAMP signaling, while D2R activation inhibits these effects (Neves, Ram, & Iyengar, 
2002). Interestingly, some neurons in the NAc co-express both D1Rs and D2Rs. While 
the core appears to have greater segregation of D1R- and D2R-expressing neurons, as 
only 5% of the neurons co-express both receptor subtypes, 17% of the shell neurons co-
express both receptors (Bertran-Gonzalez et al., 2008). Collectively, the circuitry, 
morphology, and receptor profile of these two subregions differ and may give insight into 
the mechanism underlying selective cocaine-induced decreases in NAcSh miR-495 
expression.  
In accordance with our previous findings that acute cocaine administration 
downregulates miR-495 in both mice and rats (Oliver et al., 2014; Perrone-Bizzozero et 
al., 2009), the present experiment found that cocaine SA also downregulated miR-495 in 
NAcSh. These suppressive effects are in contrast with other addiction-related miRNAs 
whose expression levels were shown to increase in response to drugs of abuse 
(Chandrasekar & Dreyer, 2009; Hollander et al., 2010; Nudelman et al., 2010; Schaefer et 
al., 2010). The downregulation in NAcSh miR-495 expression could be due to several 
factors. While miRNAs are stable in non-neuronal cell types, some miRNAs decay at 
faster rates in neurons via activity-dependent processes (Krol et al., 2010), which could 
be triggered by cocaine. The decrease in miR-495 expression may also be due to 
transcriptional repression. miR-495 is located within miRNA cluster B of the Dlk1-Dio3 
maternally imprinted region that is under the control of Methyl-CpG-binding protein 2 
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(MeCP2) and other transcription factors (Benetatos et al., 2013). Using Mecp2-null mice, 
Wu and colleagues (2010) demonstrated increased expression of many of the miRNAs 
within this imprinted region, including miR-495. Furthermore, cocaine SA increases 
striatal MeCP2 (Im et al., 2010). It is important to note that not all of the miRNAs in this 
cluster are coordinately regulated by MeCP2 knockout (Lempiainen et al., 2013; Wu et 
al., 2010), suggesting that other regulatory mechanisms, such as pre-miRNA processing 
and/or mature miRNA stability, may play a role in controlling miRNA expression 
profiles (Joilin et al., 2014).  
Unexpectedly, we observed relatively little change in ARG expression following 
cocaine SA. Previous research has shown that repeated cocaine self-administration 
increases both Bdnf and Camk2a expression in the NAc shell (Graham et al., 2007; Wang 
et al., 2010). It is important to note that these effects were found in tissue that was 
collected either immediately or 30 min after the last self-administration session. Given 
that the present study collected tissue 1 h following the session, we may have missed the 
window to detect an increase in expression of these genes. Although we found no 
changes in Bdnf mRNA across groups, Camk2a mRNA and protein levels slightly 
decreased in the SA1 group and then returned to levels more comparable to saline 
following prolonged cocaine self-administration. Arc, on the other hand, exhibited 
expression levels that more closely resembled the inverse pattern of the NAcSh miR-495 
effects where increasing the history of cocaine SA increased Arc mRNA levels. We 
previously found that NAcSh Arc mRNA is unchanged immediately following the last of 
20 consecutive cocaine SA sessions (i.e., prolonged exposure) (Neisewander, Dickey, 
Shepard, Barnes, & Hammer, 2008), suggesting the increases are time-dependent. 
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Collectively, these data suggest that the expression patterns of ARG target genes do not 
perfectly coincide with one another, most likely because multiple mechanisms are 
involved in regulating ARGs.   
Although we found that prolonged, but not brief, cocaine SA decreases NAcSh 
miR-495 expression, other factors besides the length of cocaine history that may have 
contributed to these effects. While both groups received a comparable number of cocaine 
infusions on their respective test days, the infusion rate somewhat differed between the 
two groups. While the SA22 group had established stable lever-pressing behavior over 
several weeks, some rats in the SA1 group took close to 8 h in order to receive our 
established minimum of 12 infusions. Indeed, rate of administration has previously 
shown to produce differential changes in gene expression, where faster infusion rates (5 
vs. 100 sec) produce greater increases in NAcSh Arc mRNA expression (Samaha et al., 
2004). Additionally, the SA1 group had an extra degree of novelty on their test day 
compared to the SA22 group, where they received their first exposure to the levers and 
the cues that coincided with cocaine infusions. It is unlikely that novelty influenced the 
findings, however, since we pre-exposed all rats to the chambers on each of two 
consecutive days before the first day of SA, albeit without the levers present. 
Furthermore, we did include saline-yoked controls that were also exposed to novelty on 
the test day, but did not find any difference between the controls and the SA1 groups.  
Given that NAcSh miR-495 OE was found to facilitate extinction of cocaine CPP 
(Chapter 2), this suggests that miR-495 may be involved in motivation for cocaine. 
According to Robinson and Berridge’s (1993) theory of incentive sensitization, two 
dissociable processes in the form of ‘liking’ and ‘wanting’ change over the course of 
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addiction. While the initial hedonistic value of the drug-taking experience (i.e. ‘liking’) 
appears to decrease or remain stable over time, the motivation to seek out drug (i.e. 
‘wanting’) increases and can persist even after extended periods of discontinued drug use 
(Lamb et al., 1991; Robinson & Berridge, 1993, 2008). Therefore, it is reasonable to 
suggest that rats that received prolonged cocaine SA were more motivated for cocaine 
than those that received brief exposure and decreases in NAcSh miR-495 expression may 
be indicative of increased motivation. 
 Collectively, our results suggest that miR-495 is regulated in the NAc in a time- 
and region-specific manner where miR-495 is selectively downregulated in the NAcSh 
following prolonged cocaine SA. Given our previous findings with countering cocaine’s 
effect on miR-495 and ARG expression using the lentiviral-mediated OE approach 
(Chapter 2a), this information will provide direction into where and when manipulation 
of miR-495 may be most useful to test its function in cocaine SA.   
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CHAPTER 4 
EFFECT OF NUCLEUS ACCUMBENS MIR-495 OVEREXPRESSION ON 
COCAINE SELF-ADMINISTRATION 
The SA model offers advantages, in addition to its strong validity, in allowing 
researchers to capture specific aspects of drug-taking behavior by using different 
schedules of reinforcement. Low fixed ratio (FR) schedules are typically used to test the 
effect of a manipulation on the sensitivity to the reinforcing effects of drugs across 
several doses (i.e., dose-response curve). Manipulations that shift the dose-response curve 
to the left and/or upward are interpreted as an increase in sensitivity/reinforcement, 
whereas shifts to the right and/or downward are regarded as a decrease in 
sensitivity/reinforcement (Ahmed & Koob, 1998). Another common FR procedure used 
for tapping into aspects of addiction is the extended access model, where animals are 
given extended (6h/day), but not restricted (2h/day), access to daily SA on an FR 
schedule. This model is believed to produce a behavioral phenotype that mimics the 
escalation of drug intake observed in human drug addicts (Everitt & Robbins, 2005).  
The progressive ratio (PR) schedule, on the other hand, is a high effort, high 
demand schedule where the response requirement for each successive reinforcer increases 
exponentially across a single session. Effects on PR measures are believed to reflect not 
only reinforcing efficacy of a drug, but also how hard an animal is willing to work for a 
drug reinforcer (Richardson & Roberts, 1996). In other words, the PR schedule requires 
an animal to assign incentive/motivational value to the drug that is indicated by the 
“break point.” Typically, break point is defined operationally as the final schedule 
completed before meeting a criterion used to determine that the animal is no longer 
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motivated to continue exerting effort for a drug reinforcer (e.g., 1 h elapses without 
completing the next ratio requirement). In terms of clinical translation, this schedule may 
highlight the SUD symptom that involves spending increasing amounts of time and effort 
to obtain drug (Roberts, Morgan, & Liu, 2007). Indeed, Roberts et al. (2007) have argued 
that the PR schedule is especially suited to tap into addiction-like phenotypes in rodents. 
Therefore, examining both low and high ratio schedules during SA can give a clearer 
picture of what processes are being affected by an experimental manipulation.  
In addition to active drug-taking behavior during SA, the extinction/reinstatement 
model has been useful in examining the incentive motivation to seek drug when the drug 
is no longer available. Following SA, animals undergo extinction training where they are 
placed back into the SA chamber and the levers no longer produce consequences. High 
rates of responding occur during the first few sessions, operationally defined as seeking 
behavior in the absence of drug. Over time, the animal learns that the levers no longer 
produce drug and will decrease the rate of responding. Then during reinstatement testing,  
stimuli previously associated with drug (e.g., drug-paired cues, drug priming injection, 
etc.) are presented and the rate of responding increases significantly compared to the low 
extinction baseline. This latter procedure allows researchers to examine the underlying 
neural mechanisms of individual factors known to elicit drug-seeking behavior, thereby 
identifying potential interventions aimed at attenuating drug craving in humans addicts 
(Markou et al., 1993).  
Recent evidence has shown that manipulating miRNA expression in the brain can 
alter SA behavior through suppressing target ARG expression.  Hollander and colleagues 
(2010) found that viral-mediated OE of dorsal striatal miR-212 prevents escalation of 
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cocaine SA (Hollander et al., 2010). This effect appears to be driven by miR-212-induced 
suppression of MeCP2 expression (Im et al., 2010). Furthermore, alcohol-dependent rats 
exhibit increases in miR-206 in the mPFC, a brain region involved in executive control of 
drug-seeking behavior (Kalivas & Volkow, 2005). Viral-mediated OE in mPFC miR-206 
creates an alcohol-dependent phenotype in rats (Tapocik et al., 2014), which is mediated 
in part by miR-206-targeted suppression of BDNF (Tapocik et al., 2014). Indeed, 
decreases in BDNF in the mPFC are associated with increasing motivation to self-
administer cocaine on a PR schedule (Sadri-Vakili et al., 2010). These examples provide 
evidence that altering levels of miRNAs in specific brain regions can alter facets of drug 
SA through regulating target ARG expression. 
ARG targets of miR-495, Bdnf and Camk2a, both have facilitating roles in 
cocaine SA and seeking behavior (Anderson et al., 2008; Graham et al., 2007; Loweth et 
al., 2010; Wang et al., 2010). Specifically, knockdown of both NAc Bdnf and Camk2a 
decreases cocaine SA (Graham et al., 2007; Wang et al., 2010). Given that 1) the effects 
of Camk2a were found in the NAcSh, 2) NAcSh miR-495 OE decreases expression of 
both Bdnf and Camk2a expression (Table 1) (Bastle et al., 2014), and 3) miR-495 
expression is selectively downregulated in the NAcSh following prolonged cocaine SA 
(Chapter 3), we predicted that NAcSh miR-495 OE would decrease levels of these genes 
and decrease cocaine SA. We tested these effects across both FR5 and PR schedules of 
cocaine SA, as well as during extinction and cue and cocaine-primed reinstatement. We 
also tested the specificity of our cocaine effects by using a non-drug food reinforcer.  
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Methods 
 
Animals 
Male Sprague–Dawley rats (Charles River, San Diego, CA) (200-225g) were 
individually housed in a climate-controlled facility with a 14-h dark/light cycle (lights off 
at 7 AM) with ad libitum access to food and water unless otherwise specified in the 
procedures. Housing and care were conducted in accordance with the 8th ed. Guide for 
the Care and Use of Laboratory Animals (Committee, 2011). Prior to surgery, animals 
were acclimated to handling (~2 min/day) for 7 days. 
Surgery and Intracranial Viral Infusions 
 
 Procedures for catheter and stereotactic surgeries and intracranial viral infusions 
were identical to those described in Chapter 2 and 3, with the exception that animals from 
the food reinforcement experiment did not receive catheter surgery.  
Experiment 4a: Cocaine Self-Administration  
Cocaine SA training began 5-7 days post-surgery. Two days prior to the first 
training session, rats (n = 21) were placed on mild food restriction (18-22 g/day) that was 
maintained throughout the entire experiment. Training sessions (4 h/day; 6 days/week) 
began on a fixed ratio (FR) 1 schedule of lever presses for cocaine reinforcement (0.75 
mg/kg/0.1mL, i.v.). The reinforcement schedule was set at FR1 for the first 5 sessions 
and then advanced daily from an FR1 to FR5 once rats received at least 20 infusions/2-h 
session. Once SA infusion rates stabilized, defined as less than 10% variability per 
session across 3 consecutive days with no upward or downward trends (16–22 sessions), 
rats were given 30-min access to varying cocaine doses presented in ascending order (0.0, 
0.1, 0.32 and 1.0 mg/kg/0.1 mL, i.v.) on a FR5 schedule with a 10-min timeout period 
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between doses (Barrett, Miller, Dohrmann, & Caine, 2004). Within-session dose-
response training occurred every 2 days, alternating with access to the training dose of 
cocaine for 2-hour sessions. Once rats stabilized on the within-session dose-response for 
3 consecutive days with <15% variance in the number of infusions received across days, 
they were infused with either LV-GFP or LV-miR-495 (System Biosciences Inc.) while 
under isoflurane (2-3%) anesthesia. Total cocaine intake prior to receiving viral infusions 
was counterbalanced across groups. Beginning the following day, rats received three 
daily FR5 sessions on the training dose before beginning the test phase in order to allow 
time for the pre-miRNA encoded by the lentiviral construct to reach peak expression, as 
observed with similar constructs (Deroose et al., 2006). Rats were then tested on the 
within-session dose-response and were placed back on the training dose for the next two 
days. In order to further examine effects on an FR5 dose-response, rats were then given 
between-session access to varying doses of cocaine with each of the test doses (0.0, 0.03, 
0.1, 0.3, 1.0 mg/kg/0.1mL, FR5) available in ascending order during 2-h tests.  
Additional FR5 sessions on the training dose occurred between each test dose until 
responding was again stable across 2 sessions. Following the FR5 dose-response test 
phase, rats were given two FR5 sessions before testing on a PR schedule of reinforcement 
where the response demand increased exponentially according to the formula 5*e^(0.2n)-
5 (Richardson & Roberts, 1996), with n representing the number of reinforcers the rat 
received in the session (i.e., the progressive response requirement was 1, 2, 4, 6, 9, 12, 
15, 20, 25, 32, 40, 50, 62, 77, 95, 118, 145, 178, etc). The last ratio achieved after failing 
to attain a reinforcer in 1 h was defined as the break point. Two cocaine doses were tested 
under the PR schedule (0.375 & 0.75 mg/kg/0.1mL) in an ascending order with two 
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intervening FR5 sessions between the doses. Total lever pressing, intake, and break 
points were measured and slopes of the linear dose-response PR curve were calculated 
using the formula (Y2-Y1)/(0.75-0.375). Following testing, rats were sacrificed and brain 
tissue was collected to verify cannula placement using cresyl violet staining.  
Experiment 4b: Cocaine Self-Administration, Extinction, Reinstatement  
Rats (n = 28) were trained in a similar manner as those in Experiment 4a, except 
they were given food ad libitum once they stabilized on an FR5 schedule. Once stability 
was reached under unrestricted food conditions, rats were infused with either LV-GFP or 
LV-miR-495 into the NAcSh as described previously. Total cocaine intake prior to 
receiving viral infusions was counterbalanced across groups. One week following viral 
infusions, rats received six daily FR5 sessions (0.75 mg/kg/infusion, i.v.). Once their 
intake was stable across 3 consecutive sessions on the training dose, rats were tested on a 
PR schedule of reinforcement at the same dose. After completion of PR testing, the rats 
would switch to the next dose and the same steps were taken to stabilize on an FR5 
schedule and then test on a PR schedule at the respective cocaine dose. The doses were 
administered in a pseudorandom order: 0.75, 0.375, 1.5, and 0.1875 mg/kg/infusion.  
Following the final PR test, rats were placed on the training dose (0.75 
mg/kg/infusion) on an FR5 schedule of reinforcement for at least 3 sessions. Then rats 
received daily 1-h extinction sessions for at least 10 days, where lever presses produced 
no consequences. Once each rat achieved an extinction criterion of <20% of highest 
response during extinction or <20 responses in a session for 3 consecutive sessions, they 
were tested for cue reinstatement in a 1-h test session. On the test day, the light and tone 
cues were presented response-contingently on an FR1 schedule and were presented non-
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contingently only if the rat did not press the active lever within the first 5 min of the test 
session. Rats were then re-stabilized under extinction conditions before testing for 
cocaine-primed reinstatement. The day before testing, rats were injected with saline (1 
mL/kg) to acclimate them to being injected. Rats did not reinstate lever pressing 
following saline injections (data not shown). The next day rats were tested for cocaine-
primed reinstatement by receiving a cocaine injection (10 mg/kg, i.p.) prior to being 
placed into the operant conditioning chamber. Lever pressing during the 1-h cocaine-
primed reinstatement test produced no consequences. Following testing, one half of the 
rats were transcardially perfused with 4% paraformaldehyde and brain tissue was 
collected for GFP histology and immunohistochemistry. The other half the rats were 
sacrificed and brain tissue was rapidly extracted, frozen using 2-methylbutane (-50˚C), 
and stored at -80˚C until further processing.  
Experiment 4c: Food Reinforcement 
 Rats (n = 20) were handled daily for 1 week prior to receiving training to lever 
press for food reinforcement (45 mg pellet, BioServ, Frenchtown, NJ, USA) in 30-min 
daily sessions, initially on an FR1 schedule of reinforcement. Advancement of the 
reinforcement schedule was identical to the procedure used in the cocaine SA 
experiments, except that rats were maintained on 16 g of rat chow/day until stabilized on 
an FR5 schedule, at which point they received 18 g/day (i.e., restricted). Once stable on 
an FR5 schedule, rats were infused with their assigned virus (LV-GFP or LV-miR-495) 
into the NAcSh, where group assignment was counterbalanced for previous total food 
intake during training. Rats were given one week of recovery, followed by one week of 
daily FR5 sessions, and then they received a PR test. Following testing, rats received 
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food ad libitum for the remainder of the experiment. To demonstrate varying degrees of 
motivation for food, rats were tested one week later on a PR schedule following daily 
exposure to food ad libitum (i.e., unrestricted). Following testing, rats were transcardially 
perfused with 4% paraformaldehyde and brain tissue was collected for GFP histology and 
immunohistochemistry. 
Histology and Immunohistochemistry 
For Experiment 4a, the harvested brains were sectioned using a cryostat (-20°C). 
The sections were mounted on gel-coated slides and stained with cresyl violet to 
determine cannula placement. Only rats with correct placements were included in the 
final analysis.  
For GFP histology and double-label immunohistochemistry, rats from Experiment 
4b and 4c were perfused transcardially with 4% paraformaldehyde (PFA) and their brains 
were post-fixed in PFA for 24-h, followed by serial increases in sucrose solutions (15%, 
then 30%). Brains were then frozen at -80°C until sectioned at 40 µm using a cryostat (-
20°C). For GFP histology, sections were immediately mounted on gel-coated glass slides 
using Vectashield+DAPI mounting medium (Vector Labs, Burlingame, CA, USA). For 
immunohistochemistry, free-floating sections were washed in 0.1 M phosphate buffered 
solution (PBS), then incubated in 50 mM ammonium chloride for 30 min, 3% normal 
goat serum (NGS) for 2 h, and mouse anti-NeuN (1:1000; MAB377, EMD Millipore, 
Darmstadt, Germany) or rabbit anti-GFAP (1:1000; AB7260, Abcam, Cambridge, MA, 
USA) antibodies in a solution containing 0.1% bovine serum albumin, 0.2% Triton X-
100, and 2% NGS for 48 h. Following incubation in the primary antibody, sections were 
washed and incubated in Alexa Fluor 555 anti-mouse (1:1000; A31570, Life 
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Technologies, Grand Island, NY, USA) or Alexa Fluor 555 anti-rabbit (1:1000; A31572, 
Life Technologies, Grand Island, NY, USA) secondary antibody for 1 h, then washed and 
mounted on gel-coated glass slides using Vectashield+DAPI mounting medium (Vector 
Labs). Images of the sections were captured using a Hamamatsu Digital Camera 
(Hamamatsu City, Japan) attached to an Olympus BX53 microscope at 20x magnification 
and automated stitching software (cellSens Dimension, Olympus, Center Valley, PA, 
USA). GFP, DAPI, and either NeuN or GFAP staining were overlayed using Adobe 
Photoshop (Adobe Systems, Inc., San Jose, CA, USA). 
qRT-PCR and Western Blot 
 Procedures were identical to those described in Chapters 2 and 3.  
Data Analysis 
Pre-virus intake and qRT-PCR data was analyzed using independent-samples 
student t-tests. SA data was analyzed using a mixed-factor two-way ANOVA with Dose, 
Day, and Food Restriction condition as within-subjects factors and Virus as a between-
subjects factor. Significant interactions for both experiments were followed by tests for 
simple effects. Comparisons of interest were analyzed using t-tests with Bonferroni 
correction for multiple comparisons (alpha level/number of comparisons). Results were 
considered statistically significant if p < 0.05. 
Results 
Effects on an FR5 schedule of cocaine reinforcement 
 The within-session FR5 dose-response curve in Experiment 4a showed a non-
significant trend toward a slight shift to the right in the LV-miR-495 group compared to 
the LV-GFP group (Fig. 14; Dose: F(3, 30) = 31.45, p < 0.0001; Virus: F(1, 10) = 0.02, n.s.; 
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Dose x Virus: F(3, 30) = 1.78, n.s.). When the data were analyzed as a change in infusion 
rates compared to baseline there was a significant interaction between Dose and Virus 
(Dose: F(3, 30) = 4.75, p < 0.01; Virus: F(1, 10) = 0.93, n.s.; Dose x Virus: F(3, 30) = 2.95, p < 
0.05. Subsequent post-hoc tests for simple effects revealed that when the 0.32 mg/kg dose 
of cocaine was available, the LV-miR-495 group showed an increase in infusions earned 
compared to the LV-GFP group (Fig. 15). Furthermore, trend analysis revealed that the 
LV-miR-495 group had a significant cubic trend for the difference-from-baseline curve 
(F(1, 5) = 14.58, p < 0.05), whereas the LV-GFP group had no such trend (n.s.). 
Subsequent testing on a between-session cocaine dose-response revealed that the cocaine 
self-administration dose-effect curve was again slightly shifted to the right in the LV-
miR-495 group compared to the LV-GFP group, where the LV-miR-495 group had 
decreased intake at the low 0.032 cocaine dose when measuring total infusions (Fig. 16A; 
Dose: F(4, 60) = 61.65, p < 0.0001; Virus: F(1, 15) = 0.23, n.s.; Dose x Virus: F(4, 60) = 2.23, p 
= 0.08; post-hoc Bonferroni, p < 0.05) and increased intake at the 1.0 mg/kg cocaine dose 
when measuring total mg/kg (Fig. 16B; Dose: F(3, 45) = 320.7, p < 0.0001; Virus: F(1, 15) = 
1.26, n.s.; Dose x Virus: F(3, 45) = 4.10, p < 0.05; tests for simple effects, p < 0.05).  
 During FR5 testing in Experiment 4b and 4c, NAcSh miR-495 OE had no effect 
on intake across cocaine doses (Fig. 17; Dose: F(3, 60) = 176.97, p < 0.01; Virus: F(1, 20) = 
0.02, n.s.; Virus x Dose: F(3, 60) = 0.85, n.s.) or food intake (Fig. 18; Day: F(6, 84) = 8.30, p 
< 0.0001; Virus: F(1, 14) = 0.23, n.s.; Day x Virus: F(3, 60) = 1.83, n.s.). 
Effects on a PR schedule of cocaine reinforcement 
In Experiment 4a where we tested PR measures on two cocaine doses (0.375 and 
0.75 mg/kg/infusion), we found that the LV-GFP group exhibited a dose-dependent 
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increase in responding and intake at the 0.75 versus the 0.375 mg/kg dose, whereas the 
LV-miR-495 group did not exhibit an increase in any of the measures (Fig. 19A, B; 
Dose: active lever presses, intake, F(1, 14) = 19.77, 25.64, ps < 0.001, respectively; Virus: 
active lever presses, intake, F(1, 14) = 0.52, 0.31, n.s., respectively; Dose x Virus: active 
lever presses, intake, F(1, 14) = 5.75, 6.41, ps < 0.05, respectively, tests for simple effects, 
LV-GFP, ps < 0.05, LV-miR-495, n.s.). Furthermore, by calculating the slope of the 
dose-response curves, we found that the LV-GFP group had a significantly higher slope 
than the LV-miR-495 (Fig. 19C, D; active lever presses, intake, t(15) = 2.40, 2.53, ps < 
0.05), suggesting that the OE of miR-495 attenuated motivation for cocaine. The 
representative cumulative response records in Figure 20 depict a lower break point in the 
LV-miR-495 group compared to the LV-GFP group for the higher 0.75 mg/kg dose. We 
found no effect on inactive lever pressing (Fig. 21; Dose, F(1, 10) = 1.19; Virus, F(1, 10) = 
0.002; Dose x Virus, F(1, 10) = 1.69, all n.s.). 
Our results from Experiment 4b support our PR findings in Experiment 4a where 
we found that NAcSh miR-495 OE decreased responding and intake on a PR schedule 
compared to LV-GFP controls, regardless of cocaine dose (Fig. 22; Dose: active lever 
pressing, intake F(3, 60)  = 8.98, 13.70, ps < 0.01, respectively; Virus: active lever pressing, 
intake, F(1, 20) = 7.14, 5.55, ps < 0.05 respectively; Virus x Dose: active lever pressing, 
intake, F(3, 60) = 2.23, 0.65, n.s., respectively). We found no effect on inactive lever 
pressing (Fig. 23; Dose, F(3, 60) = 1.33; Virus, F(1, 20) = 0.71; Dose x Virus, F(3, 60) = 0.17, 
all n.s.).   
For Experiment 4c where we measured food reinforcement on a PR schedule, we 
subjected rats to varying levels of food restriction to parallel differences in motivational 
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value obtained using low and high cocaine doses on a PR schedule. Similar to increasing 
the incentive value for cocaine by increasing the dose, food has increased incentive value 
in hungry rats compared to sated rats. Indeed, we found that rats that had been food-
restricted (18g/day) exhibited higher responding and intake than those that had been 
unrestricted (Fig. 24; Food Restriction: active lever pressing, intake, F(1, 14) = 55.26, 
45.97, ps < 0.001, respectively). Importantly, both groups exhibited similar levels of 
motivation for food under both feeding conditions (Fig. 24; Virus: active lever pressing, 
intake, F(1, 14) = 0.02, 0.06, n.s., respectively; Virus x Food Restriction: active lever 
pressing, intake, F(1, 14) = 0.003, 0.06, n.s., respectively). This finding suggests a selective 
effect of miR-495 OE on motivation for cocaine. We also found no effect on inactive 
lever pressing (Fig. 25; Food Restriction, F(1, 14) = 0.24, n.s.; Virus: F(1, 14) = 0.01, n.s.; 
Food Restriction x Virus, F(1, 14) = 5.62, p < 0.05, tests for simple effects, all n.s.). 
Effects on extinction and reinstatement 
 Rats in Experiment 4b went on to undergo testing for extinction and cue and 
cocaine-primed reinstatement. Before extinction testing, rats received at least 3 sessions 
on an FR5 schedule of cocaine reinforcement on the training dose. We found no group 
difference in active lever pressing during these baseline sessions before extinction (Fig. 
26; t17 = 0.70, n.s.). During extinction, NAcSh miR-495 OE decreased active lever 
pressing during the first 3 sessions compared to LV-GFP controls (Fig. 26; Day: F(9, 180) = 
19.36, p < 0.001; Virus: F(1, 20) = 3.19, p = 0.09; Virus x Day: F(9, 180) = 3.17, p < 0.01, 
post-hoc tests for simple effects, ps < 0.05). We found no group differences for inactive 
lever pressing during extinction (Fig. 27; Day: F(9, 180) = 2.90, p < 0.05; Virus: F(1, 20) = 
1.46, n.s.; Day x Virus, F(9, 180) = 1.48, n.s.). We then tested rats for both cue and cocaine-
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primed reinstatement. While both virus groups showed a similar degree of cue 
reinstatement (Fig. 28A; Day: F(1, 20) = 56.17, p < 0.001; Virus: F(1, 20) = 2.54, n.s.; Day x 
Virus, F(1, 20)  = 2.48, n.s.), the LV-miR-495 group exhibited reduced cocaine-primed 
reinstatement compared to the LV-GFP controls (Fig. 28B; Day: F(1, 20) = 38.35, p < 
0.001; Virus: F(1, 20) = 6.55, p < 0.05; Virus x Day: F(1, 20) = 6.32, p < 0.05, post-hoc tests 
for simples effects, p < 0.05). No group differences were found for inactive lever pressing 
during reinstatement testing (Fig. 29; Cue Day, F(1, 20) = 1.73; Cue Virus, F(1, 20) = 0.73; 
Cue Dose x Virus, F(1, 20) = 0.93; Coc Day, F(1, 20) = 1.55; Coc Virus, F(1, 20) = 1.55; Coc 
Dose x Virus, F(1, 20) = 1.35, all n.s.). Collectively, these results suggest that NAcSh miR-
495 OE decreases motivation to both self-administer and seek cocaine. 
Effects on ARG expression 
Following testing, qRT-PCR and Western blot analysis was used to measure 
levels of miR-495 and ARG expression. We verified that the LV-miR-495 group 
exhibited greater NAcSh miR-495 expression than the LV-GFP group (Fig. 30; t6 = 3.70, 
p < 0.05). We found that miR-495 OE reduced NAcSh Arc mRNA (Fig. 31A; t8 = 1.95, p 
< 0.05, one-tailed), but not protein (Fig. 31B; t6 = 1.06, n.s.). miR-495 OE also reduced 
NAcSh Camk2a mRNA and protein (Fig. 32; mRNA, protein, t8 = 1.63, 2.23, p ≤ 0.05, 
one-tailed, respectively). miR-495 OE had no effect on NAcSh Bdnf mRNA expression 
(Fig. 33; Bdnf-L, Bdnf-Pan, t8 = 1.27, 1.00, n.s., respectively).  
Histology and Immunohistochemistry 
 Only rats with >50% of GFP expression within the NAcSh were included in the 
final analysis (Fig. 34). Twelve rats (Experiment 4a, n = 2; Experiment 4b, n = 6; 
Experiment 4c, n = 4) were excluded due cannula and virus misplacement. We also found 
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through double-labeling immunohistochemistry that GFP co-labels preferentially with the 
neuronal marker, NeuN, and not the astrocyte marker, GFAP (Fig. 35).  
Discussion 
Here we find that NAcSh miR-495 OE decreases several measures of motivation 
for cocaine, including SA on a PR schedule of reinforcement, extinction responding, and 
cocaine-primed reinstatement. We also examined whether the same manipulation altered 
motivation for food on a PR schedule and found no effect, suggesting our motivational 
effects were specific to cocaine. Furthermore, we found that increasing NAcSh miR-495 
levels decreased levels of Camk2a and Arc expression, suggesting possible molecular 
mechanisms underlying our behavioral effects.  
During cocaine SA, we utilized both low FR5 and effortful PR schedules of 
reinforcement to examine whether miR-495 had an effect on reinforcement and/or 
motivation to self-administer cocaine. We observed slight changes in the FR5 dose-
response curve (Experiment 4a), where the LV-miR-495 group’s curve was slightly 
shifted to the right, suggesting decreased sensitivity/reinforcement. However, upon 
further examining this effect in a different group of animals (Experiment 4b), we did not 
observe any change on the FR5 schedule. Collectively, these findings suggest miR-495 
had little to no impact on the reinforcing properties of cocaine. We did observe consistent 
decreases in responding and intake in the LV-miR-495 group when cocaine was available 
on the high effort PR schedule. These findings are believed to model an aspect of SUD 
related to an individual increasing time and energy spent on drug-seeking and drug-taking 
behavior (Roberts et al., 2007). In order to rule out impairment in motor activity required 
to press a high number of times on PR schedule, we used a similar procedure with a 
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natural food reinforcer. We found no reduction in PR measures for food reinforcement, 
suggesting that our effects were not due to impairment in high rates of responding and 
that our effects on motivation were specific to cocaine.  
We further tested motivation for cocaine during extinction and reinstatement to 
examine if miR-495 OE would suppress seeking behavior in the absence of cocaine. We 
found that NAcSh miR-495 OE reduced active lever presses during the first three 
sessions of extinction, where cocaine-seeking behavior was at its highest. We also found 
decreases in cocaine-primed reinstatement following miR-495 OE. Although we didn’t 
detect a statistically significant effect during cue reinstatement, the pattern is similar. The 
lack of the effect on cue reinstatement may also highlight the more prominent role of the 
NAc core in regulating cue reinstatement (Fuchs, Evans, Parker, & See, 2004). 
Collectively, our results suggest motivation to both self-administer and seek cocaine was 
blunted by NAcSh miR-495 OE.  
We chose to target the NAcSh for miR-495 OE given our previous finding that 
prolonged cocaine SA decreases miR-495 in the shell, but not the core (see Chapter 3). 
Furthermore, both Bdnf and Camk2a facilitate cocaine abuse-related behaviors in this 
subregion (Anderson et al., 2008; Graham et al., 2007; Wang et al., 2010). Although we 
didn’t detect a miR-495 OE-induced decrease in Bdnf mRNA in the present study, we 
have previously shown that NAcSh miR-495 OE decreases both Bdnf-L and Bdnf-Pan 
mRNA in the NAc (See Chapter 2). Similarly, increases in endogenous miR-495 
expression in Mecp2-null mice are associated with diminished Bdnf expression (Wu et 
al., 2010). The inverse relationship between miR-495 and BDNF is also observed in the 
human prefrontal cortex (Mellios et al., 2008) and in the hippocampus of adolescent rats 
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upon binge-like alcohol exposure (Prins, Przybycien-Szymanska, Rao, & Pak, 2014). 
Furthermore, knockdown of local Bdnf in the NAc using a Cre-Lox recombination 
approach decreases cocaine self-administration in mice (Graham et al., 2007). It should 
be noted that these effects occurred on an FR schedule of cocaine reinforcement. 
Alternatively, shRNA-mediated knockdown of Camk2a in the NAcSh decreases cocaine 
self-administration on a PR, but not FR schedule, closely mirroring our effects (Wang et 
al., 2010). Due to CaMKII’s pervasive role in several signaling pathways, our effects 
may also involve miR-495-induced downregulation of CaMKII and its target activity. For 
instance, CaMKII has previously been implicated in SUD-related processes through its 
ability to regulate phosphorylation and stability of ΔFosB (Robison et al., 2013), 
trafficking of GluR1 subunit-containing AMPA receptors (Anderson et al., 2008; Loweth 
et al., 2010), CREB activity (Loweth et al., 2010; Wu & McMurray, 2001), and A-type 
K+ currents (Kourrich et al., 2012). Most importantly, CaMKII has been identified in 
silico as a common, central node in positive feedback gene regulatory pathways involved 
with drug addiction (Li et al., 2008). These feedback loops have been hypothesized to 
further strengthen and perpetuate the molecular underpinnings of addiction, thus 
suggesting that CaMKII signaling is critical in this disorder. 
Given that several miR-495 targets are plasticity-related genes, miR-495 OE is 
likely altering plasticity-related activity of infected NAcSh neurons, thereby altering drug 
motivational processes. Indeed, the NAcSh plays a role in inhibition of drug seeking, but 
not food seeking (Millan & McNally, 2011; Peters et al., 2008; Sutton et al., 2003). 
While the NAcSh may be recruited for drug and non-drug reinforcement, the plasticity 
occurring during drug reinforcement may be distinct from non-drug reinforcers. This is 
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supported by work demonstrating that distinct populations of neurons are active during 
drug versus non-drug goal-directed behavior (Cameron & Carelli, 2012; Carelli, Ijames, 
& Crumling, 2000). Furthermore, previous work has shown that manipulations of NAc 
Bdnf and Camk2a levels alter drug-, but not food-, seeking behavior (Graham et al., 2007; 
Wang et al., 2010), suggesting these are indeed “addiction”-related genes that specifically 
control drug abuse-related processes. Consistent with this line of reasoning, we found that 
NAcSh miR-495 OE had no impact on motivation to seek food reinforcement, even 
though these genes were also downregulated. Therefore, NAcSh miR-495 OE may be 
reversing the drug-induced plasticity involved in motivation for cocaine that is not shared 
by natural reinforcers.  
Another factor that may relate to our effects is the cell-type specific functions of 
NAc neurons. As mentioned previously, the NAc contains neurons that either 
predominantly express D1R or D2Rs. Recent work has shown that optogenetic 
stimulation of D2R-containing neurons in the NAc prevents compulsive cocaine SA in 
mice, while D1R stimulation has no effect (Bock et al., 2013). Furthermore, cell type-
specific loss of BDNF signaling or the histone methyltransferase G9a in either D1R or 
D2R has opposite effects on cocaine reward CPP (Lobo et al., 2010; Maze et al., 2014). 
In general, loss of BDNF signaling disinhibits the cell, leading to increases in activity. 
Similar to the findings from Bock and colleagues (2103), loss of BDNF in D2R-
containing neurons leads to decreases in cocaine CPP by increasing activity of these cells 
(Lobo et al., 2010). Under normal conditions, G9a suppresses gene expression to control 
developmental cell-type specification (Maze et al., 2014). Loss of G9a in D2R neurons 
results in increased gene expression profiles, anatomical circuitry, and 
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electrophysiological properties that resemble D1R neurons, which leads to increases in 
cocaine reward CPP (Maze et al., 2014). Additionally, ∆FosB overexpression in D1R, but 
not D2R, neurons increases Camk2a expression and this leads to increases in cocaine 
reward CPP (Kelz et al., 1999; Robison et al., 2013). These examples provide evidence 
for cell-type specific effects within the same brain region. Given that our viral 
manipulation likely infected NAc neurons without preference for either D1R- versus 
D2R-containing neurons, our effects may change depending on the specific cell type that 
miR-495 is altered. Based on these previous findings, our manipulation may have 
increased D2R neuronal activity and/or suppressed D1R activity. Further work into this 
area is warranted.  
In conclusion, we demonstrated that NAcSh miR-495 OE reduces motivation to 
both self-administer and seek cocaine, but not food reinforcement. These findings open 
new avenues for future research on the specific genes and pathways responsible for the 
reductions in motivation, the role of miR-495 in regulating different forms of synaptic 
plasticity in the NAc, and whether specific cell types affected by miR-495 in the NAc 
may be driving the distinct neural circuits underlying drug motivation. The possibility of 
globally targeting drug-induced changes in gene expression via miRNAs, such as miR-
495, may lead to new therapeutics that shift the balance of gene regulation toward 
alleviating, rather than promoting, SUD-related behavior. 
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CHAPTER 5 
EFFECT OF NUCLEUS ACCUMBENS MIR-495 INHIBITION ON 
 COCAINE SELF-ADMINISTRATION 
While overexpression of miRNAs provides information on how reducing target 
gene expression impacts drug abuse-related behavior, miRNA inhibition provides 
information on how disinhibiting and increasing target gene expression may produce 
opposite behavioral effects. Since a given mRNA is regulated by several different 
miRNAs (Doench & Sharp, 2004), inhibiting one miRNA may not disinhibit all target 
mRNA expression. One factor that increases the degree miRNA-mediated regulation is 
the number of binding sites in the 3’UTR, where a greater number increases the 
magnitude and probability of repression (Brennecke, Stark, Russell, & Cohen, 2005). 
Indeed, miR-495 has greater binding efficacy and repression for Bdnf-L (5 sites) over 
Bdnf-S (1 site) (Oliver et al., 2014). In addition to number of binding sites, several other 
factors influence miRNA-mRNA interactions, including thermodynamic stability, 
conserved seed regions across species, and G-U wobbles (Brennecke et al., 2005; Doench 
& Sharp, 2004; Stark, Brennecke, Russell, & Cohen, 2003). Therefore, the subset of 
mRNAs that are disinhibited by miRNA inhibition suggests that expression of those 
particular mRNAs is governed strongly by that specific miRNA.  
Several methods have been used to inhibit miRNA action, including antisense 
oligonucleotides, gene knockout, and sequestering transcripts (e.g., sponges) (Ruberti, 
Barbato, & Cogoni, 2012). Antisense oligonucleotides (ASO) are small strands of 
complementary nucleic acids that will bind to the target sequence and “inactivate it” or 
prevent it from being expressed. Several chemical modifications can be made to ASOs in 
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order to increase stability, affinity, and cellular and tissue uptake. For example, locked 
nucleic acid (LNA) ASOs are particularly effective at miRNA suppression due to 
additions of a 2’, 4’ methylene bridge in the ribose. LNAs targeting miR-212 have been 
shown to produce opposite behavioral effects on cocaine SA as OE (Hollander et al., 
2010). One disadvantage of this method is that it requires repeated administrations 
directly into tissues of interest (e.g., brain) in order to get long-lasting inhibition. Another 
approach is to knockout miRNA genes from the genome using Cre-Lox recombination or 
CRISPR-Cas9 gene editing technology. Both procedures silence target gene expression 
by excising specific DNA sequences. One disadvantage is that several miRNA genes 
reside within clusters in the DNA. Therefore, knocking out one miRNA gene may affect 
the transcriptional processing and ultimate expression of the other miRNAs in the cluster. 
For instance, miR-495 is located within the miRNA cluster B of the Dlk1-Dio3 
maternally imprinted region (Benetatos et al., 2013). Finally, sequestering transcripts is 
another way to inhibit endogenous miRNA action. This approach involves synthesizing a 
protein-coding transcript with a 3’UTR that contains several adjacent binding sites for a 
particular miRNA of interest (i.e., sponge) (Ebert, Neilson, & Sharp, 2007). Once 
transfected into cells, endogenous miRNAs will bind to the sponge transcript and prevent 
miRNA:target mRNA interaction. One of the advantages of this approach is that the 
transcript can be packaged into a viral vector in order to transfect and express a sponge 
construct for long periods of time. However, as with all of these approaches, target gene 
expression changes need to be validated. 
In order to directly compare the effects miR-495 OE on cocaine abuse-related 
behaviors (Chapter 4) to those produced by miR-495 knockdown, we created a sponge 
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construct that could be packaged into a lentiviral vector for long-term miR-495 
inhibition. The sponge construct contained six miR-495 binding sites in the 3’UTR. We 
first verified that this manipulation effectively prevented miR-495-induced repression of 
reporter activity in vitro (data not shown). Given that increases in target gene expression, 
such as Bdnf and Camk2a, in the NAc lead to increases in cocaine abuse-related behavior 
(Bahi et al., 2008; Loweth et al., 2010), we predicted that sponge-mediated miR-495 
inhibition would increase motivation to self-administer and seek cocaine through 
disinhibition of target ARG expression. Here, we tested the effect of the miR-495 sponge 
on cocaine reinforcement under FR5 and PR schedules, and during extinction and 
reinstatement of cocaine-seeking behavior.    
Methods 
 Procedures for animals, surgery, intracranial viral infusions, cocaine self-
administration, extinction, reinstatement, histology and immunohistochemistry, qRT-
PCR, Western blot and data analysis were identical to those described for Chapter 4. The 
only exception was that rats were infused with either LV-GFP or LV-miR-495-sponge 
(LV-Sponge), which expressed a GFP reporter that contained 6 miR-495 binding sites in 
the 3’UTR. The complementary base pairing included a bulge (mismatched pairing) so 
that endogenous miR-495 would not result in endonucleolytic cleavage of the sponge 
transcript.  
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Results 
Effects on FR5 and PR schedule of cocaine reinforcement 
LV-sponge had no effect on intake across cocaine doses on an FR5 schedule (Fig. 
36; Dose: F(3, 63) = 150.80, p < 0.01; Virus: F(1, 21) = 0.32, n.s.; Virus x Dose: F(3, 63) = 
0.43, n.s.). LV-Sponge also had no effect on responding or intake on a PR schedule 
 (Fig. 37; Dose: active lever pressing, intake F(3, 63)  = 9.62, 13.50, ps < 0.01, respectively; 
Virus: active lever pressing, intake, F(1, 21) = 1.69, 0.50, n.s., respectively; Virus x Dose: 
active lever pressing, intake, F(3, 63) = 1.95, 0.96, n.s., respectively), as well as no effect on 
inactive lever pressing (Fig. 38; Dose, F(3, 63) = 1.57; Virus, F(1, 21) = 0.49; Dose x Virus, 
F(3, 63) = 0.15, all n.s.). 
Effects on extinction and reinstatement 
We found no group difference in active lever pressing during the baseline before 
extinction (Fig. 39; t18 = 1.48, n.s.). Interestingly, the LV-Sponge group exhibited 
decreased active lever pressing during the first extinction session compared to LV-GFP 
controls (Fig. 39; Day: F(9, 189) = 22.13, p < 0.001; Virus: F(1, 21) = 2.50, n.s.; Day x Virus: 
F(9, 189) = 5.03, p ≤ 0.05, post-hoc tests for simple effects, p < 0.05). We found no group 
differences for inactive lever pressing during extinction (Fig. 40; Day: F(9, 189) = 1.01; 
Virus: F(1, 21) = 0.06; Day x Virus, F(9, 189) = 1.30, all n.s.). We then tested rats for both cue 
and cocaine-primed reinstatement. While there was no significant difference between 
virus groups in the degree of cue reinstatement (Fig. 41A; Day: F(1, 21) = 72.29, p < 0.001; 
Virus: F(1, 21) = 0.83, n.s.; Day x Virus, F(1, 21)  = 0.66, n.s.), the LV-Sponge group 
exhibited a trend toward a reduction in cocaine-primed reinstatement compared to the 
LV-GFP controls (Fig. 41B; Day: F(1, 21) = 45.32, p < 0.001; Virus: F(1, 21) = 3.05, p = 
 57 
0.10; Virus x Day: F(1, 21) = 3.47, p = 0.08, post-hoc Bonferroni, test day, p = 0.09). No 
group differences were found for inactive lever pressing during reinstatement testing 
(Fig. 42; Cue Day, F(1, 21) = 0.18; Cue Virus, F(1, 21) = 0.22; Cue Dose x Virus, F(1, 21) = 
1.09; Coc Day, F(1, 21) = 2.76; Coc Virus, F(1, 21) = 0.03; Coc Dose x Virus, F(1, 21) = 0.002, 
all n.s.). Collectively, these results suggest that blockade of endogenous miR-495 slightly 
decreases motivation to seek cocaine. 
Effects on ARG expression 
Following testing, qRT-PCR and Western blot analysis were used to measure 
levels of miR-495 and ARG expression. We found no differences in NAcSh miR-495 
(Fig. 43; t7 = 1.01, n.s.), Camk2a (Fig. 44; mRNA, protein, t10 = 0.69, 0.44, n.s., 
respectively), or Bdnf (Fig. 45; Bdnf-L, Bdnf-Pan, t10 = 1.36, 1.31, n.s., respectively) 
expression between the LV-GFP and LV-Sponge groups. Interestingly, we found that 
LV-Sponge exhibited reduced NAcSh Arc mRNA (Fig. 46A; t10 = 1.83, p < 0.05, one-
tailed), but not protein (Fig. 46B; t6 = 1.02, n.s.).  
Discussion 
  Here we find that inhibition of NAcSh miR-495 slightly reduces motivation to 
seek cocaine, evident as a decrease in cocaine-seeking behavior during the first extinction 
session. However, this manipulation failed to alter SA on either reinforcement schedule 
tested. Furthermore, reinstatement of cocaine seeking by either cues or cocaine priming 
did not differ between virus groups, although there was a non-significant trend toward a 
decrease in cocaine-primed reinstatement. The behavioral effects observed are contrary to 
our hypothesis that LV-sponge would increase motivation for cocaine; however, post-
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mortem measures of ARG expression revealed a decrease in Arc mRNA in the LV-
sponge group compared to LV-GFP controls, but no change in miR-495 and other ARGs.  
 Although we observed no differences in miR-495 expression between the two 
virus groups, this is likely because sponge constructs typically sequester, and not 
degrade, target miRNAs (Ebert & Sharp, 2010). The mechanism underlying sponge-
mediated reduction in Arc expression, however, is unknown, but could be due to several 
factors. One possibility is that since the binding sites for miR-495 are AU rich, this may 
result in other molecules binding to similar sequences and being sequestered by the 
sponge transcript. Indeed, several RNA-binding proteins (RBP) preferentially bind to 
AU-rich elements (ARE) in the 3’UTR of mRNAs (e.g., HuR, HuD, KSRP, etc.). Since 
several RBPs stabilize bound mRNAs and increase expression, sequestering these RBPs 
could leave target transcripts more vulnerable to degradation processes. Similarly, 
miRNA inhibition-mediated increases in specific target genes will create competition 
among transcripts for RBPs. One target gene may receive preferential stabilization, while 
others will be left vulnerable. Recent work has shown that Camk2a and Kv1.1 mRNA can 
act as a “sponge” for the RPB HuD, depending on the level of mTOR signaling (Sosanya 
et al., 2015; Sosanya et al., 2013). Therefore, sponge-mediated increases in certain miR-
495 target genes may leave Arc mRNA vulnerable to degradation. Additional work is 
needed to directly test this hypothesis.  
 Interestingly, some of the changes observed with LV-sponge are similar to those 
observed previously with miR-495 OE. Both manipulations decreased cocaine-seeking 
behavior during extinction and Arc mRNA expression. In contrast, miR-495 OE, but not 
LV-sponge, also reduced responding on a progressive ratio schedule of cocaine 
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reinforcement and cocaine-primed reinstatement of extinguished cocaine-seeking 
behavior, as well as reduced Camk2a and Bdnf expression. Much work has demonstrated 
a role of Camk2a in drug abuse-related behavior. Bi-directional regulation of NAc 
Camk2a levels and activity produces opposite effects on psychostimulant-induced 
behavior (Anderson et al., 2008; Loweth et al., 2010; Wang et al., 2010), where Camk2a 
expression facilitates abuse-related behavior. Therefore, the greater suppression of 
motivation for cocaine following OE compared to LV-sponge may be due to Camk2a 
downregulation.  
 Much less is known about Arc’s role in motivation for drug, but previous work 
has shown that antisense-mediated Arc knockdown in the NAcSh reduces the expression 
of morphine CPP (Lv et al., 2011). In contrast, the same manipulation in the dorsal 
striatum increases cocaine-seeking behavior during extinction (Hearing, Schwendt, & 
McGinty, 2011). Therefore, Arc’s role in drug abuse-related behavior may be region-
specific. In addition, Arc mRNA is upregulated in several brain regions following tests 
for contextual- and cue-induced reinstatement of cocaine-seeking behavior, including in 
the mPFC, orbitofrontal cortex, NAc, and dorsal striatum (Hearing, Miller, See, & 
McGinty, 2008; Hearing, See, & McGinty, 2008; Zavala et al., 2008). More specifically, 
upregulation in the NAc occurs following context-induced reinstatement where cocaine-
seeking behavior correlates with Arc mRNA expression (Hearing, See, et al., 2008). 
While Arc mRNA is upregulated in the mPFC following cue reinstatement, no change 
occurs in the NAcSh (Zavala et al., 2008). These findings may relate to our more 
selective behavioral effects on extinction versus cue reinstatement, where Arc appears to 
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be recruited in the NAcSh during drug-seeking behavior that is evoked by contextual 
stimuli (e.g., extinction) rather than discrete cues (e.g., cue reinstatement).  
Arc is an effector immediate early gene (IEG) that is rapidly transported to 
dendrites following transcription (Dynes & Steward, 2012; Link et al., 1995; Lyford et 
al., 1995; Steward, Wallace, Lyford, & Worley, 1998), where it can undergo local 
translation and participate in structural and synaptic plasticity (Korb & Finkbeiner, 2011). 
Specifically, Arc protein regulates spine density, spine type, long-term potentiation (LTP) 
and depression (LTD), and homeostatic plasticity (Bramham et al., 2008). Although Arc 
has several roles in synaptic plasticity, one common consequence of Arc knockdown is 
impairment in AMPA receptor endocytosis, leading to increased surface AMPA receptor 
expression (Chowdhury et al., 2006). This leads to impairment in LTD, where neurons 
have increased firing rates (Shepherd et al., 2006). Given that activity in the NAcSh is 
associated with inhibiting drug-seeking behavior during extinction, perhaps 
downregulation of Arc expression leads to increased surface AMPA receptor expression 
and activity of viral-infected NAcSh neurons, thereby leading to decreases in drug-
seeking behavior during extinction. Indeed, viral-mediated upregulation of GluR1 and 
GluR2 AMPA receptor expression in the NAcSh facilitates extinction of cocaine-, but not 
sucrose-, seeking behavior (Sutton et al., 2003). Future work into the role of NAcSh Arc 
in extinction of cocaine-seeking behavior is warranted.  
In conclusion, we found that our attempt to inhibit miR-495 expression in the 
NAcSh with LV-sponge failed to increase cocaine abuse-related behaviors and ARG 
expression, but instead attenuated cocaine-seeking behavior during extinction, as well as 
Arc mRNA expression in NAcSh. Although unexpected, these data support our overall 
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hypothesis that downregulating ARG expression reduces cocaine abuse-related behavior. 
Importantly, given that miR-495 OE is more effective than the sponge construct at 
reducing both ARG expression and motivation for cocaine, this further supports the idea 
of using miRNAs at tools for targeting several genes simultaneously for greater 
regulation of drug abuse-related behavior.   
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CHAPTER 6 
CONCLUDING REMARKS 
This dissertation aimed to test the hypothesis that NAc miR-495 regulates cocaine 
abuse-related behavior by targeting ARG expression. The main findings that support this 
hypothesis include: 1) NAcSh miR-495 OE attenuated motivation for cocaine during 
extinction of cocaine CPP, cocaine SA on a PR schedule of reinforcement, and cocaine-
seeking behavior during both extinction and cocaine-primed reinstatement, 2) NAcSh 
miR-495 OE decreased ARG expression, 3) NAcSh miR-495 OE had no effect on food 
reinforcement on a PR schedule or the rewarding properties of cocaine as measured by 
expression of cocaine CPP and cocaine SA on an FR5 schedule of reinforcement, 4) NAc 
miR-495 levels were reduced and ARG levels were increased in rats following 
prolonged, but not brief, cocaine SA, and 5) sequestration of NAc miR-495 expression 
unexpectedly decreased both cocaine-seeking behavior during extinction and expression 
of the ARG, Arc, in the NAcSh. Collectively, these exciting findings demonstrate miR-
495 as a novel target for reducing addiction-like phenotypes.  
Candidate Mechanisms 
The NAcSh was chosen as our target region for miR-495 manipulation based on 
the region-specificity of its predicted ARG targets and their known effects in this region 
on cocaine abuse-related behaviors, as well as the NAc miR-495 expression profile 
following cocaine SA (Chapter 3). Previous work has established a role of the NAcSh in 
regulating drug-seeking behavior. While some have found that pharmacological 
inhibition increases drug seeking during extinction (Di Ciano, Robbins, & Everitt, 2008; 
Millan et al., 2010; Peters et al., 2008), others have shown reductions in cocaine-primed 
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reinstatement of drug seeking (Famous et al., 2008). These discrepancies may be due to 
NAcSh activity regulating drug abuse-related processes across different behavioral 
domains. Specifically, extinction normally inhibits drug seeking such that inactivation of 
the NAcSh prevents this effect, resulting in an increase in the behavior. In contrast, 
cocaine priming normally facilitates drug seeking such that inactivation of the NAcSh 
attenuates the behavior. Perhaps NAcSh miR-495 OE reduced cocaine-seeking behavior 
during extinction by facilitating extinction learning, whereas the same manipulation 
reduced cocaine-primed reinstatement of cocaine seeking by attenuating the motivational 
effects of cocaine. Although further research is needed to understand the psychological 
processes responsible for the behavior effects observed, the findings suggest that the 
molecular consequences of miR-495 OE underlie these behavioral changes. 
Arc is involved in AMPA-receptor endocytosis (Chowdhury et al., 2006); thereby 
reductions in Arc expression are associated with increases in surface AMPA receptor 
expression and activity (Shepherd et al., 2006). Extinction also increases AMPA receptor 
expression in the NAcSh and viral-mediated increases in NAcSh GluR1/2 expression 
enhance extinction of cocaine-seeking behavior (Sutton et al., 2003). Therefore, the 
facilitated extinction of cocaine-seeking behavior and reductions in Arc expression in 
both the LV-miR-495 and LV-Sponge groups may be due to decreases in Arc-mediated 
AMPA receptor endocytosis.  
CaMKII is involved in the insertion of GluR1 into NAcSh synapses and blocking 
this effect decreases cocaine-primed reinstatement (Anderson et al., 2008). We observed 
reductions in Camk2a expression and cocaine-primed reinstatement in the LV-miR-495 
group, but not in the LV-Sponge group, consistent with the idea that Camk2a expression 
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may be involved in cocaine-primed reinstatement. This idea is further supported by our 
observation that cocaine SA on a PR schedule of cocaine reinforcement was attenuated in 
the LV-miR-495 group, but not in LV-Sponge group, consistent with previous work 
demonstrating that NAcSh Camk2a knockdown decreases cocaine SA on a PR schedule 
(Wang et al., 2010). While their roles may be more or less pronounced depending on the 
type of behavioral test (i.e., PR, extinction, reinstatement), both Arc and Camk2a may be 
working in concert to alter NAcSh activity to suppress motivation for cocaine across 
several domains of behavior. Future work is needed to directly test these hypotheses.   
The role of Bdnf in our effects is less clear, as we did not observe a significant 
change in expression following either miR-495 OE or inhibition (Chapter 4, 5). 
Furthermore, previous work has primarily linked reductions in NAc Bdnf expression with 
decreases in cocaine CPP expression and cocaine SA on an FR5 schedule of 
reinforcement (Bahi et al., 2008; Graham et al., 2007), both of which were unaffected by 
NAcSh miR-495 OE. Therefore, the potential role of NAcSh Bdnf in our effects on 
motivation for cocaine is currently unknown.   
Limitations of the present research 
Our findings are exciting as they are the first to identify a miRNA involved in 
regulating motivation to seek cocaine. However, future work is needed to explore the 
generalizability of our effects, specifically across drug class, sex, and age. Our finding 
that NAcSh miR-495 OE specifically decreases motivation for cocaine, but not food, 
needs to be investigated for other drugs of abuse. Nearly every drug of abuse increases 
dopamine levels in the NAc (Hyman et al., 2006), but the mechanism for this effect 
differs across drug classes. Furthermore, ARGs can have opposing roles on drug abuse-
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related behavior depending on the drug class. For example, manipulation of VTA BDNF 
signaling has opposite effects on cocaine and morphine abuse-related behavior (Graham 
et al., 2009; Koo et al., 2012; Lu, Dempsey, Liu, Bossert, & Shaham, 2004). Given that 
polydrug abuse is common, future work aimed at testing the effects of miR-495 on other 
drugs of abuse is warranted. 
Sex differences in drug abuse research exist both in animal and human studies 
(Carroll & Anker, 2010). In animal studies, female rodents predominantly exhibit higher 
reinforcement and motivation for drugs across multiples phases of dependence (for 
review, see Carroll & Anker, 2010). Similarly, women tend to transition from initiation to 
treatment quicker and have greater psychological, physical, and work-related 
complications associated with drug use than men (Hernandez-Avila, Rounsaville, & 
Kranzler, 2004). Additionally, recent work has shown that the transcriptional profiles in 
the NAc differ considerably across male and female rodents following chronic variable 
stress (Hodes et al., 2015), a known predictor of drug abuse liability (Enoch, 2011). 
Given that all of the previous research on the role miRNAs and drug abuse-related 
behavior has been performed in adult males, research is needed to examine these effects 
in females. 
Drug use is often initiated during adolescence (Breslau & Peterson, 1996; Kandel 
& Logan, 1984) and adolescent rodents are typically more sensitive to the rewarding and 
reinforcing effects of drug (O'Dell, 2009; Wong, Ford, Pagels, McCutcheon, & Marinelli, 
2013). Neurobiological differences in the brain reward circuitry exist between 
adolescents and adults, including differences in basal dopamine levels (Matthews, Bondi, 
Torres, & Moghaddam, 2013; Stansfield & Kirstein, 2005; Walker et al., 2010), 
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dopamine innervation between midbrain and striatal regions (Haycock et al., 2003), and 
D1/D2 receptor expression (Meng, Ozawa, Itoh, & Takashima, 1999; Teicher, Andersen, 
& Hostetter, 1995). Therefore, drug-induced gene expression changes likely differ 
depending on the age of the organism. For instance, heroin seeking produces attenuated 
immediate early gene expression (i.e., Fos protein) in the mPFC of adolescents compared 
to adults (Doherty, Cooke, & Frantz, 2013). Given that drug abuse often begins in 
adolescence, the anti-motivational effects of NAc miR-495 need to be tested at this 
developmental stage when rodents and humans are particularly vulnerable to drug effects.  
Future Directions 
Effect of Environmental Enrichment and Abstinence on miRNA Expression 
We have previously found that animals housed in enriched environments (EE; 
e.g., groups of 4-6 rats, novel toys, exercise, etc.) exhibit dramatically reduced cocaine-
seeking behavior compared to animals in isolated housing conditions (Thiel et al., 2012; 
Thiel, Sanabria, Pentkowski, & Neisewander, 2009). Furthermore, EE reduces the 
incubation effect, where cocaine-seeking behavior increases as the withdrawal period 
increases (Grimm et al., 2003; Tran-Nguyen et al., 1998). Given that these manipulations 
produce vastly different levels of motivation for cocaine, miR-495 may underlie these 
changes. We are in the process of performing RNA-seq on brain tissue from animals 
trained to cocaine self-administration who were subsequently housed in isolation versus 
EE during a long versus short period of forced abstinence.  This study replicated our 
previous findings that motivation to seek cocaine varies greatly across groups, providing 
a means to examine correlations between miRNA levels, including miR495, and 
motivation for cocaine. This study will provide information on the natural alterations in 
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miRNA expression that accompany changes in drug-seeking behavior and may point to 
novel miRNAs involved in drug motivation.  
Competition between miR-495 and HuD 
 In addition to miRNAs, other molecules post-transcriptionally regulate gene 
expression. As mentioned previously, RNA-binding proteins (RPBs) can also bind to 
3’UTRs of target mRNAs affecting their stability and expression levels. For instance, 
HuD, also known as ELAV4, is a neuron-specific RBP that binds to AU-rich elements on 
mRNAs and stabilizes target gene expression (Allen et al., 2013; Sosanya et al., 2015; 
Sosanya et al., 2013; Tsai, Cansino, Kohn, Neve, & Perrone-Bizzozero, 1997). Given that 
the seed region for miR-495 bindings sites is also AU-rich, HuD competes for control of 
ARG expression in vitro, where miR-495 decreases and HuD increases ARG expression 
(Gardiner, Oliver, & Perrone-Bizzozero, 2013). In contrast to miR-495, cocaine increases 
HuD expression in the NAc (Oliver, Gardiner, Brigman, Allan, & Perrone-Bizzozero, 
2015). Furthermore, transgenic mice with HuD overexpression in forebrain neurons 
exhibit increases in cocaine CPP (Oliver et al., 2015). This suggests that HuD may 
stabilize target ARG expression and promote cocaine abuse-related behaviors. Examining 
the competition between miRNAs and RBPs in drug abuse-related behavior is a very 
exciting and relatively unexplored area in the field.  
miRNAs as Biomarkers for Disease 
 Given their widespread role in gene regulation, miRNAs are attractive targets for 
treating complex neuropsychiatric disorders that are not caused by one single gene, but 
multiple interacting cellular processes (Goldman, Oroszi, & Ducci, 2005; Li et al., 2008). 
One exciting new field in the study of miRNAs and disease is using miRNA expression 
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profiles as biomarkers for susceptibility to neuropsychiatric disorders, including drug 
abuse. Small RNAs can be secreted from the tissue of origin and circulate in peripheral 
body fluids, such as plasma or cerebrospinal fluid (Redis, Calin, Yang, You, & Calin, 
2012). Circulating miRNAs can travel in exosomes and/or bind to and travel with high-
density lipoproteins, which increase their stability (Kosaka et al., 2010; Vickers, 
Palmisano, Shoucri, Shamburek, & Remaley, 2011). One challenge in using miRNAs as 
biomarkers is relating the changes in circulating miRNA levels with those occurring in 
the brain, although some evidence suggests these can be related (Drusco et al., 2015; Liu 
et al., 2010). Research has already begun to examine circulating miRNAs in the context 
of drug abuse (Beech et al., 2014; Gardiner et al., 2015). Although this field is in its 
relative infancy, circulating miRNAs have exciting potential for use as biomarkers that 
can characterize disease progression and severity, as well as point to novel and perhaps 
individualized treatments. 
Conclusion 
This dissertation supports the hypothesis that NAc miR-495 regulates motivation 
for cocaine through targeting several ARGs. Potential mechanisms underlying these 
effects include altering the synaptic plasticity and activity of NAcSh neurocircuitry 
through targeting ARG expression, thereby reducing the motivation to seek cocaine. 
Future lines of work will explore: 1) the competition between miRNAs and other post-
transcriptional regulators of gene expression, 2) the influence of other mediating factors 
in drug abuse on miRNA expression (e.g, drug class, sex, age, social environment, etc.), 
and 3) the diagnostic value of miRNAs as biomarkers for addiction-like phenotypes. The 
findings from this dissertation point to an exciting new avenue in understanding the 
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influence of microRNAs on the development, expression, and possible treatment for 
SUDs.  
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Table 1. Microarray Results of Putative miR-495 Targets Downregulated by miR-495 
OE. Rats were infused with either LV-GFP or LV-miR-495 and NAc tissue was collected 
one week later. Affymetrix® Rat Gene 2.0 ST arrays (Santa Clara, CA, USA) were used 
to determine changes in gene expression (n = 3/ group). Data was normalized using 
Robust multi-array average (RMA) and significant changes in expression were 
determined with MeV4_9_0 software (Boston, MA, USA) using a t-test with Bonferroni 
corrections and permutation validations. (Top) Candidate miR-495 target mRNAs found 
within TargetScan that were significantly downregulated (fold change ≤0.75 and p<0.05) 
by miR-495 OE in NAcSh. (Bottom) Downregulated miR-495 target mRNAs also found 
within the KARG database. * downregulation confirmed by qRT-PCR.  
  
Down <0.75 and TS 
t
a
r
g
e
t
s
             
 
Adrbk2, *Arc, Arhgap5, Atp2b2, Bcl11a, *Bdnf, Cacna1d, *Camk2a, 
Camk2g, Clmn, Cnr1, Cpeb2, Cpne4, Dcaf6, Dlgap2, Dmd, Dpp10, 
Drp2, Dyrk2, Ephb2, Fat4, Gabbr2, Gpr22, Gpr3, *Gria3, Hivep2, 
Kctd16, Lancl2, Large, Lhx2, Limch1, Lrrc57, Mapk10, Mast4, 
Mcf2l, Nacc2, Nat8l, Ncam2, Neurod6, Nfib, Nmt2, Nptxr, Nr4a3, 
Nrxn1, Ntm, Pcdh9, Pde4d, Per2, Pgr, Pitpnm3, Pou6f1, Ppargc1a, 
Ppme1, Prickle1, Psme3, Ptprd, Pura, R3hdm2, Rap1gap2, 
Rimbp2, Rims4, Satb1, Satb2, Scn8a, Shank2, Slit1, Smad9, Sox5, 
*Stmn2, Tcf4, Tgfb2, Tmeff2, Tox, Usp32, Xylt1, Zfhx4 
Down <0.75, TS targets, 
KARG      
*Arc, *Bdnf, Cacna1d, *Camk2a, Cnr1, Gabbr2, Mapk10, Nacc2, 
Nfib, Nr4a3, Per2, Ppargc1a, Ppme1, Pura, *Stmn2 
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Figure 1. MicroRNA Biogenesis and Function. MicroRNAs are transcribed similarly to 
protein-coding RNAs, except they form a stem-loop structure following transcription (i.e, 
pri-miRNA). The enzyme, Drosha, trims the ends of the stem (i.e., pre-miRNA) to 
prepare for exportation from the nucleus via Exportin 5. Once in the cytoplasm, Dicer 
cleaves the loop of the pre-miRNA, producing a double-stranded RNA. One strand (i.e., 
mature miRNA) is incorporated into the miRNA-induced silencing complex (miRISC). 
Upon binding to a complementary sequence in the 3’ untranslated region of a target 
mRNA, either translational repression, deadenylation, or endonucleolytic cleavage may 
occur. All three mechanisms lead to decreases in resulting protein.  
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Figure 2. NAc Shell miR-495 Overexpression Blocked Cocaine-Induced Downregulation 
of NAc miR-495. Rats were infused with either LV-GFP or LV-miR-495 into the 
NAcSh. Two weeks later, rats received an injection of saline (1 mL/kg, i.p.) or cocaine 
(15 mg/kg, i.p.) and were sacrificed 2 h later (n = 5-6/group). NAc tissue was collected 
and processed for qRT-PCR using Taqman® primers for miR-495 or U6 snRNA 
(control). Rel. miR-495 levels were normalized to U6. Error bars indicate S.E.M. * 
different from LV-GFP-saline, + different from LV-miR-495-cocaine, ps < 0.05.  
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Figure 3. NAc Shell miR-495 Overexpression Reduced NAc Bdnf mRNA. Rats were 
infused with either LV-GFP or LV-miR-495 into the NAcSh. Two weeks later, rats 
received an injection of saline (1 mL/kg, i.p.) or cocaine (15 mg/kg, i.p.) and were 
sacrificed 2 h later (n = 5-6/group). NAc tissue was collected and processed for qRT-PCR 
using primers for Bdnf-Pan (A), Bdnf-L (B) or Gapdh mRNA (control). Rel. Bdnf mRNA 
levels were normalized to GAPDH. Error bars indicate S.E.M. * different from LV-GFP-
saline, + different from LV-miR-495-cocaine, ps < 0.05, ** p < 0.01. 
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Figure 4. NAc Shell miR-495 Overexpression Had No Effect on Cocaine CPP 
Expression. Rats were infused with either LV-GFP (n =8) or LV-miR-495 (n = 9) into the 
NAcSh. One week later, rats were conditioned with cocaine (15 mg/kg, i.p.) on the 
initially non-preferred side that was established during baseline. Saline was conditioned 
on the initially preferred side. All rats received 4 conditioning sessions that alternated 
between cocaine and saline (a total of 2 cocaine and 2 saline conditioning sessions). Each 
30-min conditioning session was given once/day. The day following the last conditioning 
session, the rats were place in the CPP apparatus and allowed access to both sides for 15 
min. Dashed line represents 50% of total session length. Error bars indicate S.E.M. * 
main effect of day, p < 0.05.  
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Figure 5. NAc Shell miR-495 Overexpression Facilitated Cocaine CPP Extinction. 
Following test day, rats were placed back in the CPP apparatus for 15-min extinction 
sessions where they were allowed free access between both sides of the chamber (n = 8-
9/group). Dashed line represents 50% of total session length. Error bars indicate S.E.M. + 
Test day vs. Ext. 3 for the LV-miR-495 group, p < 0.025, Bonferroni correction.  
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Figure 6. NAc Shell miR-495 Overexpression Increased NAc miR-495 and Decreased 
NAc Bdnf mRNA Expression. One day following the last extinction session, rats were 
sacrificed and NAc tissue was collected and processed for qRT-PCR using Taqman® 
primers for miR-495 (A) or U6 snRNA (control) and primers for Bdnf-L (B), Bdnf-Pan 
(C) or GAPDH mRNA (control). Relative miR-495 levels were normalized to U6 and 
relative Bdnf mRNA levels were normalized to GAPDH. n = 8-9/group. Error bars 
indicate S.E.M. * different from LV-GFP group, p < 0.05, ** p < 0.01.  
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Figure 7. Tissue Punch Method for NAc Core and Shell Collection. Frozen brains were 
placed in a rat brain matrix, sliced into 2 mm thick sections using razor blades, and 
punches were taken that corresponded to the landmarks near the NAc (e.g., anterior 
commissure). First, the core (gray dashed circle) was collected with a 1.25 mm tissue 
punch, and then the shell (black dashed circle) was collected with a 2 mm tissue punch.  
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Figure 8. Self-Administration Behavior Across Different Levels of Training. Rats were 
randomly assigned to receive either 1 (SA1; n = 11) or 22 d (SA22; n = 12) of cocaine 
SA training (0.9375 mg/kg/infusion, i.v.). Test day refers to the day that the respective 
groups were sacrificed where the SA1 group was sacrificed 1 h following the first 
session, and the SA22 group was sacrificed 1 h following the 22nd session (A, C). There 
was no difference between the two groups in the total number of active lever presses (B) 
or number of cocaine infusions received (D). Error bars indicate S.E.M.  
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Figure 9. Prolonged, but Not Brief, Cocaine Self-Administration Decreases NAc Shell 
miR-495 Expression. Rats received either 1 or 22 d of cocaine SA (0.9375 mg/kg, i.v.; n 
= 11-12/group). Controls received saline infusions yoked to a cocaine partner (n = 11). 
One hour following the last SA session, rats were sacrificed and NAcSh tissue was 
collected and processed for qRT-PCR using Taqman® primers for miR-495 or U6 
snRNA (control). Rel. miR-495 levels were normalized to U6. Error bars indicate S.E.M. 
* different from Saline, + different from SA1 group, Tukey ps < 0.05.  
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Figure 10. Cocaine Self-Administration Had No Effect on NAc Core miR-495 
Expression. Rats received either 1 or 22 d of cocaine SA (0.9375 mg/kg, i.v.; n = 11-
12/group). Controls received saline infusions yoked to a cocaine partner (n = 11). One 
hour following the last SA session, rats were sacrificed and NAcC tissue was collected 
and processed for qRT-PCR using Taqman® primers for miR-495 or U6 snRNA 
(control). Rel. miR-495 levels were normalized to U6. Error bars indicate S.E.M.  
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Figure 11. Cocaine Self-Administration Had No Effect on NAc Shell Bdnf mRNA 
Expression. Rats received either 1 or 22 d of cocaine SA (0.9375 mg/kg, i.v.; n = 11-
12/group). Controls received saline infusions yoked to a cocaine partner (n = 11). One 
hour following the last SA session, rats were sacrificed and NAcSh tissue was collected 
and processed for qRT-PCR using primers for Bdnf-L (A), Bdnf-Pan (B) or Gapdh 
mRNA (control). Rel. Bdnf mRNA levels were normalized to Gapdh. Error bars indicate 
S.E.M.  
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Figure 12. Prolonged, but Not Brief, Cocaine Self-Administration Increased NAc Shell 
Arc mRNA. Rats received either 1 or 22 d of cocaine SA (0.9375 mg/kg, i.v.; n = 11-
12/group). Controls received saline infusions yoked to a cocaine partner (n = 11). One 
hour following the last SA session, rats were sacrificed and NAcSh tissue was collected 
and processed for qRT-PCR using primers for Arc (A) or Gapdh mRNA (control). Rel. 
Bdnf mRNA levels were normalized to Gapdh. (B) Arc protein was quantified using 
Western blot and normalized to GAPDH protein. Representative blots are depicted for 
each group. Error bars indicate S.E.M. * Bonferroni correction, p ≤ 0.025.  
  
Saline SA1 SA22
0.0
0.1
0.2
0.3
0.4
R
el
. D
en
si
ty
Arc Protein
GAPDH 
Arc 
Saline SA1 SA22
0.0
0.5
1.0
1.5
2.0
2.5
R
el
. A
rc
 m
R
N
A
Arc mRNA
*
A B 
 100 
 
 
 
 
 
Figure 13. Effect of Cocaine Self-Administration on NAc Shell Camk2a Expression. 
Rats received either 1 or 22 d of cocaine SA (0.9375 mg/kg, i.v.; n = 11-12/group). 
Controls received saline infusions yoked to a cocaine partner (n = 11). One hour 
following the last SA session, rats were sacrificed and NAcsh tissue was collected and 
processed for qRT-PCR using primers for Camk2a (A) or Gapdh mRNA (control). Rel. 
Camk2a mRNA levels were normalized to Gapdh. (B) CaMKIIα protein was quantified 
using Western blot and normalized to GAPDH protein. Representative blots are depicted 
for each group. Error bars indicate S.E.M. * Tukey, p < 0.05.  
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Figure 14. NAc Shell miR-495 Overexpression Slightly Shifted the Within-Session FR5 
Dose-Response Curve to the Right. Rats were initially trained on within-session dose-
response sessions on an FR5 schedule where each dose (0.0, 0.1, 0.32. and 1.0 
mg/kg/infusion) was presented for 30 min each in an ascending order. Once stability was 
achieved (A), rats were infused with either LV-GFP or LV-miR-495 (n = 8-9/group). (B) 
Four days later, rats were tested on the within-session dose-response for one session. 
Error bars indicate S.E.M. 
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Figure 15. Change from Baseline During the Within-Session FR5 Dose-Response Curve. 
Rats were initially trained on within-session dose-response sessions on an FR5 schedule 
where each dose (0.0, 0.1, 0.32. and 1.0 mg/kg/infusion) was presented for 30 min each 
in an ascending order. Once stability was achieved, rats were infused with either LV-GFP 
or LV-miR-495 (n = 8-9/group). Four days later, rats were tested on the within-session 
dose-response for one session. Error bars indicate S.E.M. * different from LV-GFP, p < 
0.05.  
  
Change from baseline
0.0 0.1 0.32 1.0
-10
-5
0
5
10
Cocaine Dose (mg/kg/infusion)
In
fu
si
on
s/
30
 m
in
 (T
es
t -
 B
as
el
in
e)
 
* LV-GFP
LV-miR-495
 103 
 
 
 
Figure 16. NAc Shell miR-495 Overexpression Slightly Shifted the Between-Session 
FR5 Dose-Response Curve to the Right. One week following virus infusions (n = 8-
9/group), rats received cocaine doses (0.0, 0.032, 0.1, 0.032, 1.0 mg/kg/infusion) during 
2-h sessions in an ascending order where both total infusions (A) and intake (B; mg/kg) 
were measured. Error bars indicate S.E.M. * different from LV-GFP, p < 0.05. 
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Figure 17. NAc Shell miR-495 Overexpression Had No Effect on a Between-Session 
FR5 Dose-Response Curve. Two weeks following virus infusions (n = 10-12/group), rats 
received cocaine doses on an FR5 schedule of reinforcement during 2-h sessions in a 
pseudorandom order (0.75, 0.38, 1.5, 0.19 mg/kg/infusion). Infusions were averaged 
across 3 sessions once rats achieved stability (< 15% variability). Error bars indicate 
S.E.M. 
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Figure 18. NAc Shell miR-495 Overexpression Had No Effect on Food Intake on an FR5 
Schedule. One weeks following virus infusions (n = 8/group), rats received food 
reinforcement on an FR5 schedule of reinforcement during 30-min sessions for 7 
sessions. Error bars indicate S.E.M. 
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Figure 19. NAc Shell miR-495 Overexpression Reduced PR Measures. Rats (n = 8-
9/group) received cocaine doses (0.375, 0.75 mg/kg/infusion) on a PR schedule of 
reinforcement in an ascending order where both total active lever presses (A) and intake 
(B) were measured. Dose-effect curve slopes [(Y2-Y1)/(0.75-0.375)] were measured for 
active lever presses (C) and intake (D). Error bars indicate S.E.M. + different from the 
0.375 dose in LV-GFP group, p < 0.05. * different from LV-GFP, p < 0.05. 
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Figure 20. NAc Shell miR-495 Overexpression Reduced Break Points on a PR Schedule. 
Cumulative response record for representative rats in the LV-GFP and LV-miR-495 
groups that were closest to their respective group mean at the 0.75 mg/kg/infusion dose 
on a PR schedule of cocaine reinforcement. Dotted line represents break point, where rats 
went 1 h without receiving a cocaine infusion.  
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Figure 21. NAc Shell miR-495 Overexpression Had No Effect on Inactive Lever Presses 
on a PR Schedule. Rats (n = 8-9/group) received cocaine doses (0.375, 0.75 
mg/kg/infusion) on a PR schedule of reinforcement in an ascending order. Error bars 
indicate S.E.M.  
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Figure 22. NAc Shell miR-495 Overexpression Reduced Responding and Intake on a PR 
Schedule. Rats (n = 10-12/group) received cocaine doses on a PR schedule of 
reinforcement in a pseudorandom order (0.75, 0.38, 1.5, 0.19 mg/kg/infusion) where both 
total active lever presses (A) and intake (B) were measured. Error bars indicate S.E.M. * 
different from LV-GFP group, p < 0.05. 
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Figure 23. NAc Shell miR-495 Overexpression Had No Effect on Inactive Lever Presses 
on a PR Schedule. Rats (n = 10-12/group) received cocaine doses on a PR schedule of 
reinforcement in a pseudorandom order (0.75, 0.38, 1.5, 0.19 mg/kg/infusion). Error bars 
indicate S.E.M. 
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Figure 24. NAc Shell miR-495 Overexpression Had No Effect on Responding or Intake 
on a PR Schedule of Food Reinforcement. Total responding (A) and infusions (B) for 
food reinforcement were measured on a PR schedule. Rats (n = 8/group) were initially 
tested on restricted feeding conditions (18g/day) and then tested one week later on 
unrestricted feeding conditions. Error bars indicate S.E.M.  
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Figure 25. NAc Shell miR-495 Overexpression Had No Effect on Inactive Lever Presses 
on a PR Schedule of Food Reinforcement. Rats (n = 8/group) were initially tested on 
restricted feeding conditions (18g/day) and then tested one week later on unrestricted 
feeding conditions. Error bars indicate S.E.M. 
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Figure 26. NAc Shell miR-495 Overexpression Reduced Responding During Extinction. 
Rats (n = 10-12/group) were initially given >3 sessions on an FR5 schedule of cocaine 
self-administration (SA) to establish an SA baseline. During the 1-h daily extinction 
sessions, lever presses produced no consequences. Error bars indicate S.E.M. * different 
from LV-GFP, p < 0.05. 
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Figure 27. NAc Shell miR-495 Overexpression Had No Effect on Inactive Lever 
Pressing During Extinction. Rats (n = 10-12/group) were initially given >3 sessions on an 
FR5 schedule of cocaine self-administration (SA) to establish an SA baseline. During the 
1-h daily extinction sessions, lever presses produced no consequences. Error bars indicate 
S.E.M. 
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Figure 28. NAc Shell miR-495 Overexpression Reduced Cocaine-Primed Reinstatement. 
(A) Following >3 sessions with low extinction responding (i.e., Baseline), rats (n = 10-
12/group) underwent cue reinstatement where cues that were previously presented 
response-contingently during self-administration we available on an FR1 schedule for 1 
h. (B) After re-establishing an extinction baseline, rats (n = 10-12/group) received a 
priming injection of cocaine (10 mg/kg, i.p.) and were immediately place in the operant 
chamber and were allowed to lever press under extinction conditions for 1 h. Error bars 
indicate S.E.M. + different from Baseline, p < 0.05. * different from LV-GFP, p < 0.05. 
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Figure 29. NAc Shell miR-495 Overexpression Had No Effect on Inactive Lever 
Pressing During Reinstatement. (A) Following >3 sessions with low extinction 
responding (Baseline), rats (n = 10-12/group) underwent cue reinstatement where cues 
that were previously presented response-contingently during self-administration we 
available on an FR1 schedule for 1 h. (B) After re-establishing an extinction baseline, rats 
received a priming injection of cocaine (10 mg/kg, i.p.) and were immediately place in 
the operant chamber and were allowed to lever press under extinction conditions for 1 h. 
Error bars indicate S.E.M. 
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Figure 30. NAc Shell miR-495 Overexpression Increased NAc Shell miR-495 
Expression. Following behavioral testing, NAcSh tissue (n = 5-7/group) was collected 
and processed for qRT-PCR using Taqman® primers for miR-495 or U6 snRNA 
(control). Rel. miR-495 levels were normalized to U6. Error bars indicate S.E.M. * 
different from LV-GFP, p < 0.05. 
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Figure 31. NAc Shell miR-495 Overexpression Reduced NAc Shell Arc mRNA. NAcSh 
tissue (n = 5-7/group) was collected following behavioral testing and processed for qRT-
PCR using primers for Arc (A) or Gapdh mRNA (control). Rel. Arc mRNA levels were 
normalized to Gapdh. (B) Arc protein was quantified using Western blot and normalized 
to GAPDH protein. Representative blots are depicted for each group. Error bars indicate 
S.E.M. * different from Saline, p < 0.05. 
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Figure 32. NAc Shell miR-495 Overexpression Reduced NAc Shell Camk2a Expression. 
NAcSh tissue (n = 5-7/group) was collected following behavioral testing and processed 
for qRT-PCR using primers for Camk2a (A) or Gapdh mRNA (control). Rel. Camk2a 
mRNA levels were normalized to Gapdh. (B) CaMKIIα protein was quantified using 
Western blot and normalized to GAPDH protein. Representative blots are depicted for 
each group. Error bars indicate S.E.M. * different from LV-GFP, p < 0.05. 
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Figure 33. NAc Shell miR-495 Overexpression Had No Effect on NAc Shell Bdnf 
mRNA Expression. NAcSh tissue (n = 5-7/group) was collected following behavioral 
testing and was processed for qRT-PCR using primers for Bdnf-L (A), Bdnf-Pan (B) or 
Gapdh mRNA (control). Rel. Bdnf mRNA levels were normalized to Gapdh. Error bars 
indicate S.E.M. 
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Figure 34. Verification of Viral Infusion Placement. The left panel is a schematic of the 
target nucleus accumbens shell (NAcSh) taken from the rat brain atlas (Paxinos & 
Watson, 2005) at +1.6mm from bregma. The right panel is a photomicrograph of a 
representative infusion site with viral-expressed GFP (green) and DAPI (blue) staining. 
Scale bar = 1 mm.  
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Figure 35. Lentiviral Vector Preferentially Co-Labels with Neurons. Double-label 
immunohistochemistry for GFP (green) and neuronal marker NeuN (Red, left panel) or 
astrocyte marker GFAP (Red, right panel). Cell bodies labeled with DAPI (blue). Scale 
bar = 50 µm.  
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Figure 36. NAc Shell miR-495 Inhibition Had No Effect on a Between-Session FR5 
Dose-Response Curve. Two weeks following virus infusions (n = 11-12/group), rats 
received cocaine doses on an FR5 schedule of reinforcement during 2-h sessions in a 
pseudorandom order (0.75, 0.38, 1.5, 0.19 mg/kg/infusion). Infusions were averaged 
across 3 sessions once rats achieved stability (< 15% variability). Error bars indicate 
S.E.M. 
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Figure 37. NAc Shell miR-495 Inhibition Had No Effect on Responding and Intake on a 
PR Schedule. Rats (n = 11-12/group) received cocaine doses on a PR schedule of 
reinforcement in a pseudorandom order (0.75, 0.38, 1.5, 0.19 mg/kg/infusion) where both 
total active lever presses (A) and intake (B) were measured. Error bars indicate S.E.M.  
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Figure 38. NAc Shell miR-495 Inhibition Had No Effect on Inactive Lever Presses on a 
PR Schedule. Rats (n = 11-12/group) received cocaine doses on a PR schedule of 
reinforcement in a pseudorandom order (0.75, 0.38, 1.5, 0.19 mg/kg/infusion). Error bars 
indicate S.E.M. 
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Figure 39. NAc Shell miR-495 Inhibition Reduced Responding During Extinction. Rats 
(n = 11-12/group) were initially given >3 sessions on an FR5 schedule of cocaine self-
administration (SA) to establish an SA baseline. During the 1-h daily extinction sessions, 
lever presses produced no consequences. Error bars indicate S.E.M. * different from LV-
GFP, p < 0.05. 
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Figure 40. NAc Shell miR-495 Inhibition Had No Effect on Inactive Lever Pressing 
During Extinction. Rats (n = 11-12/group) were initially given >3 sessions on an FR5 
schedule of cocaine self-administration (SA) to establish an SA baseline. During the 1-h 
daily extinction sessions, lever presses produced no consequences. Error bars indicate 
S.E.M. 
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Figure 41. NAc Shell miR-495 Inhibition Had No Effect on Reinstatement. (A) 
Following >3 sessions with low extinction responding (i.e., Baseline), rats (n = 11-
12/group) underwent cue reinstatement where cues that were previously presented 
response-contingently during self-administration we available on an FR1 schedule for 1 
h. (B) After re-establishing an extinction baseline, rats (n = 11-12/group) received a 
priming injection of cocaine (10 mg/kg, i.p.) and were immediately place in the operant 
chamber and were allowed to lever press under extinction conditions for 1 h. Error bars 
indicate S.E.M. + different from Baseline, p < 0.05.  
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Figure 42. NAc Shell miR-495 Inhibition Had No Effect on Inactive Lever Pressing 
During Reinstatement. (A) Following >3 sessions with low extinction responding 
(Baseline), rats (n = 11-12/group) underwent cue reinstatement where cues that were 
previously presented response-contingently during self-administration we available on an 
FR1 schedule for 1 h. (B) After re-establishing an extinction baseline, rats (n = 11-
12/group) received a priming injection of cocaine (10 mg/kg, i.p.) and were immediately 
place in the operant chamber and were allowed to lever press under extinction conditions 
for 1 h. Error bars indicate S.E.M. 
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Figure 43. NAc Shell miR-495 Inhibition Had No Effect on NAc Shell miR-495 
Expression. Following behavioral testing, NAcSh tissue (n = 5-7/group) was collected 
and processed for qRT-PCR using Taqman® primers for miR-495 or U6 snRNA 
(control). Rel. miR-495 levels were normalized to U6. Error bars indicate S.E.M.  
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Figure 44. NAc Shell miR-495 Inhibition Had No Effect on NAc Shell Camk2a 
Expression. NAcSh tissue (n = 5-7/group) was collected following behavioral testing and 
processed for qRT-PCR using primers for Camk2a (A) or Gapdh mRNA (control). Rel. 
Camk2a mRNA levels were normalized to Gapdh. (B) CaMKIIα protein was quantified 
using Western blot and normalized to GAPDH protein. Representative blots are depicted 
for each group. Error bars indicate S.E.M.  
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Figure 45. NAc Shell miR-495 Inhibition Had No Effect on NAc Shell Bdnf mRNA 
Expression. NAcsh tissue (n = 5-7/group) was collected following behavioral testing and 
was processed for qRT-PCR using primers for Bdnf-L (A), Bdnf-Pan (B) or Gapdh 
mRNA (control). Rel. Bdnf mRNA levels were normalized to Gapdh. Error bars indicate 
S.E.M. 
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Figure 46. NAc Shell miR-495 Inhibition Reduced NAc Shell Arc mRNA. NAcSh tissue 
(n = 5-7/group) was collected following behavioral testing and processed for qRT-PCR 
using primers for Arc (A) or Gapdh mRNA (control). Rel. Arc mRNA levels were 
normalized to Gapdh. (B) Arc protein was quantified using Western blot and normalized 
to GAPDH protein. Representative blots are depicted for each group. Error bars indicate 
S.E.M. * different from Saline, p < 0.05. 
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APPENDIX C 
 
LIST OF ABBREVIATIONS 
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ARG: addiction-related gene 
Arc: activity-regulated cytoskeleton-associated protein 
Bdnf: brain-derived neurotrophic factor 
Bdnf-L: brain-derived neurotrophic factor, long 3’UTR variant 
Bdnf-Pan: brain-derived neurotrophic factor, sum of long and short 3’UTR variants 
Bdnf-S: brain-derived neurotrophic factor, short 3’UTR variant 
Camk2a: calcium/calmodulin-dependent protein kinase type 2, alpha subunit 
Cnr1: cannabinoid receptor type 1 
CPP: conditioned place preference 
CREB: cAMP response element binding protein 
FR: fixed ratio 
Gapdh: glyceraldehyde 3-phosphate dehydrogenase  
GFP: green fluorescent protein 
GluR: glutamate receptor 
KARG: Knowledgebase of Addiction-Related Genes 
LV: lentivirus 
MeCP2: methyl-CpG binding protein 2 
miRNA: microRNA 
mPFC: medial prefrontal cortex 
NAc: nucleus accumbens 
NAcC: nucleus accumbens core 
NAcSh: nucleus accumbens shell 
OE: overexpression 
Per2: period circadian clock 2  
PR: progressive ratio 
RPB: RNA-binding protein 
SA: self-administration 
SUD: substance use disorder 
U6 snRNA: U6 small nuclear RNA 
UTR: untranslated region 
VTA: ventral tegmental area 
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Geeta Negi, Ph.D..  Gregory Powell, Ph.D.  
Natalie Peartree, Ph.D.  Thomas Sebastian, Ph.D. 
    
University of Minnesota, Duluth 
Tonya Meinerding, B.S.    Darcie Sackett, B.S. 
 
PROFESSIONAL ACTIVITIES 
 
Committee Service 
2016 Committee Member, Honors Thesis for Trisha Chaudhury, Arizona State University 
2015 Committee Member, Honors Thesis for Nicholas Galles, Arizona State University 
2014  Committee Member, Honors Thesis for Jeffrey Lynn, Arizona State University 
2011 Committee Member, Honors Thesis for Mari Turk, Arizona State University 
 
 
 143 
Community Service 
2016 Science Fair Judge, Chandler High School 
2014 Brain Fair, Monte Vista Elementary School 
2012 Homecoming Week Psychology Booth, Arizona State University  
2010-2012 Brain Fair, Arizona State University  
 
Scientific Service 
2015-16 Reviewer for journal article submission in Cellular and Molecular Neurobiology 
2014 Reviewer for journal article submission in Behavioral Pharmacology  
2013 Reviewer for journal article submission in Progress in Neuropsychopharmacology 
and Biological Psychiatry 
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